<?xml version="1.0" encoding="UTF-8"?><!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD v1.1 20151215//EN"  "JATS-archivearticle1.dtd"><article article-type="research-article" dtd-version="1.1" xmlns:ali="http://www.niso.org/schemas/ali/1.0/" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink"><front><journal-meta><journal-id journal-id-type="nlm-ta">elife</journal-id><journal-id journal-id-type="publisher-id">eLife</journal-id><journal-title-group><journal-title>eLife</journal-title></journal-title-group><issn pub-type="epub" publication-format="electronic">2050-084X</issn><publisher><publisher-name>eLife Sciences Publications, Ltd</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="publisher-id">31529</article-id><article-id pub-id-type="doi">10.7554/eLife.31529</article-id><article-categories><subj-group subj-group-type="display-channel"><subject>Research Article</subject></subj-group><subj-group subj-group-type="heading"><subject>Biochemistry and Chemical Biology</subject></subj-group><subj-group subj-group-type="heading"><subject>Biophysics and Structural Biology</subject></subj-group></article-categories><title-group><article-title>Novel ATP-cone-driven allosteric regulation of ribonucleotide reductase via the radical-generating subunit</article-title></title-group><contrib-group><contrib contrib-type="author" id="author-97682"><name><surname>Rozman Grinberg</surname><given-names>Inna</given-names></name><contrib-id authenticated="true" contrib-id-type="orcid">http://orcid.org/0000-0003-3094-1998</contrib-id><email>inna.rozman@dbb.su.se</email><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="fn" rid="con1"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-97683"><name><surname>Lundin</surname><given-names>Daniel</given-names></name><contrib-id authenticated="true" contrib-id-type="orcid">http://orcid.org/0000-0002-8779-6464</contrib-id><email>daniel.lundin@scilifelab.se</email><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="fn" rid="con2"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" equal-contrib="yes" id="author-97685"><name><surname>Hasan</surname><given-names>Mahmudul</given-names></name><contrib-id authenticated="true" contrib-id-type="orcid">https://orcid.org/0000-0002-1767-6440</contrib-id><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="aff" rid="aff2">2</xref><xref ref-type="fn" rid="equal-contrib1">†</xref><xref ref-type="fn" rid="con3"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" equal-contrib="yes" id="author-97686"><name><surname>Crona</surname><given-names>Mikael</given-names></name><email>mikael.crona@gmail.com</email><xref ref-type="aff" rid="aff3">3</xref><xref ref-type="fn" rid="equal-contrib1">†</xref><xref ref-type="fn" rid="con4"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" equal-contrib="yes" id="author-97687"><name><surname>Jonna</surname><given-names>Venkateswara Rao</given-names></name><contrib-id authenticated="true" contrib-id-type="orcid">http://orcid.org/0000-0001-7211-4830</contrib-id><email>venkat.jonna@gmail.com</email><xref ref-type="aff" rid="aff4">4</xref><xref ref-type="fn" rid="equal-contrib1">†</xref><xref ref-type="fn" rid="con5"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-102732"><name><surname>Loderer</surname><given-names>Christoph</given-names></name><email>Christoph.Loderer@tu-dresden.de</email><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="fn" rid="con6"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-97689"><name><surname>Sahlin</surname><given-names>Margareta</given-names></name><email>margareta.sahlin@dbb.su.se</email><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="fn" rid="con7"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-97693"><name><surname>Markova</surname><given-names>Natalia</given-names></name><email>natalia.markova@malvern.com</email><xref ref-type="aff" rid="aff5">5</xref><xref ref-type="fn" rid="con8"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-97690"><name><surname>Borovok</surname><given-names>Ilya</given-names></name><email>ilyabo@tauex.tau.ac.il</email><xref ref-type="aff" rid="aff6">6</xref><xref ref-type="fn" rid="con9"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-97691"><name><surname>Berggren</surname><given-names>Gustav</given-names></name><email>gustav.berggren@kemi.uu.se</email><xref ref-type="aff" rid="aff7">7</xref><xref ref-type="other" rid="fund2"/><xref ref-type="other" rid="fund5"/><xref ref-type="other" rid="fund6"/><xref ref-type="fn" rid="con10"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-97692"><name><surname>Hofer</surname><given-names>Anders</given-names></name><email>anders.hofer@umu.se</email><xref ref-type="aff" rid="aff4">4</xref><xref ref-type="other" rid="fund4"/><xref ref-type="fn" rid="con11"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" corresp="yes" id="author-30325"><name><surname>Logan</surname><given-names>Derek T</given-names></name><contrib-id authenticated="true" contrib-id-type="orcid">https://orcid.org/0000-0002-0098-8560</contrib-id><email>derek.logan@biochemistry.lu.se</email><xref ref-type="aff" rid="aff2">2</xref><xref ref-type="other" rid="fund2"/><xref ref-type="fn" rid="con12"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" corresp="yes" id="author-95949"><name><surname>Sjöberg</surname><given-names>Britt-Marie</given-names></name><contrib-id authenticated="true" contrib-id-type="orcid">http://orcid.org/0000-0001-5953-3360</contrib-id><email>britt-marie.sjoberg@dbb.su.se</email><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="other" rid="fund1"/><xref ref-type="other" rid="fund2"/><xref ref-type="other" rid="fund3"/><xref ref-type="fn" rid="con13"/><xref ref-type="fn" rid="conf1"/></contrib><aff id="aff1"><label>1</label><institution content-type="dept">Department of Biochemistry and Biophysics</institution><institution>Stockholm University</institution><addr-line><named-content content-type="city">Stockholm</named-content></addr-line><country>Sweden</country></aff><aff id="aff2"><label>2</label><institution content-type="dept">Department of Biochemistry and Structural Biology</institution><institution>Lund University</institution><addr-line><named-content content-type="city">Lund</named-content></addr-line><country>Sweden</country></aff><aff id="aff3"><label>3</label><institution>Swedish Orphan Biovitrum AB</institution><addr-line><named-content content-type="city">Stockholm</named-content></addr-line><country>Sweden</country></aff><aff id="aff4"><label>4</label><institution content-type="dept">Department of Medical Biochemistry and Biophysics</institution><institution>Umeå University</institution><addr-line><named-content content-type="city">Umeå</named-content></addr-line><country>Sweden</country></aff><aff id="aff5"><label>5</label><institution>Malvern Instruments Inc.</institution><country>Sweden</country></aff><aff id="aff6"><label>6</label><institution content-type="dept">Department of Molecular Microbiology and Biotechnology</institution><institution>Tel-Aviv University</institution><addr-line><named-content content-type="city">Tel Aviv-Yafo</named-content></addr-line><country>Israel</country></aff><aff id="aff7"><label>7</label><institution content-type="dept">Department of Chemistry</institution><institution>Uppsala University</institution><addr-line><named-content content-type="city">Uppsala</named-content></addr-line><country>Sweden</country></aff></contrib-group><contrib-group content-type="section"><contrib contrib-type="editor" id="author-17008"><name><surname>Berger</surname><given-names>James M</given-names></name><role>Reviewing Editor</role><aff><institution>Johns Hopkins University School of Medicine</institution><country>United States</country></aff></contrib></contrib-group><author-notes><fn fn-type="con" id="equal-contrib1"><label>†</label><p>These authors contributed equally to this work</p></fn></author-notes><pub-date date-type="publication" publication-format="electronic"><day>01</day><month>02</month><year>2018</year></pub-date><pub-date pub-type="collection"><year>2018</year></pub-date><volume>7</volume><elocation-id>e31529</elocation-id><history><date date-type="received" iso-8601-date="2017-08-26"><day>26</day><month>08</month><year>2017</year></date><date date-type="accepted" iso-8601-date="2017-12-23"><day>23</day><month>12</month><year>2017</year></date></history><permissions><copyright-statement>© 2017, Rozman Grinberg et al</copyright-statement><copyright-year>2017</copyright-year><copyright-holder>Rozman Grinberg et al</copyright-holder><ali:free_to_read/><license xlink:href="http://creativecommons.org/licenses/by/4.0/"><ali:license_ref>http://creativecommons.org/licenses/by/4.0/</ali:license_ref><license-p>This article is distributed under the terms of the <ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/licenses/by/4.0/">Creative Commons Attribution License</ext-link>, which permits unrestricted use and redistribution provided that the original author and source are credited.</license-p></license></permissions><self-uri content-type="pdf" xlink:href="elife-31529-v1.pdf"/><abstract><object-id pub-id-type="doi">10.7554/eLife.31529.001</object-id><p>Ribonucleotide reductases (RNRs) are key enzymes in DNA metabolism, with allosteric mechanisms controlling substrate specificity and overall activity. In RNRs, the activity master-switch, the ATP-cone, has been found exclusively in the catalytic subunit. In two class I RNR subclasses whose catalytic subunit lacks the ATP-cone, we discovered ATP-cones in the radical-generating subunit. The ATP-cone in the <italic>Leeuwenhoekiella blandensis</italic> radical-generating subunit regulates activity via quaternary structure induced by binding of nucleotides. ATP induces enzymatically competent dimers, whereas dATP induces non-productive tetramers, resulting in different holoenzymes. The tetramer forms by interactions between ATP-cones, shown by a 2.45 Å crystal structure. We also present evidence for an Mn<sup>III</sup>Mn<sup>IV</sup> metal center. In summary, lack of an ATP-cone domain in the catalytic subunit was compensated by transfer of the domain to the radical-generating subunit. To our knowledge, this represents the first observation of transfer of an allosteric domain between components of the same enzyme complex.</p></abstract><abstract abstract-type="executive-summary"><object-id pub-id-type="doi">10.7554/eLife.31529.002</object-id><title>eLife digest</title><p>When a cell copies its DNA, it uses four different building blocks called deoxyribonucleotides (dNTPs). These consist of one of the four ‘bases’ (A, T, C and G), which pair up to link the two strands of DNA in the double helix, bound to a sugar and a phosphate group. If the cell contains too little or too much of one of these building blocks, an incorrect base may be inserted into the DNA. This results in a mutation, which in bacteria can cause death, and in animals may lead to cancer.</p><p>The enzyme that fabricates and carefully controls the amount of each dNTP building block inside a cell is called ribonucleotide reductase. Once there are enough building blocks in a cell the enzyme is turned off. A part of the enzyme called the ATP-cone acts as an on/off switch to control this activity.</p><p>The ribonucleotide reductase consists of a large component and a small component. Until now, studies of the ATP-cone have found it only in the large component of the enzyme. However, when looking through a public database of sequence data, Rozman Grinberg et al. noticed that ribonucleotide reductases in some bacteria have their ATP-cone joined to the small component. Does this ATP-cone also control the amounts of dNTP building blocks inside cells and, if so, how?</p><p>Rozman Grinberg et al. studied one such ATP-cone in a ribonucleotide reductase from a bacterium (named <italic>Leeuwenhoekiella blandensis</italic>) found in the Mediterranean Sea. This revealed that when the amount of dNTP building blocks reaches a certain limit, the ATP-cone turns off the enzyme. Examining the three-dimensional structure of the enzyme using a technique called X-ray crystallography revealed that when turned off, the enzyme’s small components are glued together in pairs. This prevents them from working. Rozman Grinberg et al. also discovered that this enzyme contains a new type of metal center with two manganese ions suggesting that a new reaction mechanism may operate in this class of ribonucleotide reductase.</p><p>These findings support a theory that biological on/off switches can evolve rapidly. In addition to its evolutionary and biomedical interest, understanding how the ATP-cone works might help to improve the enzymes used in industrial processes.</p></abstract><kwd-group kwd-group-type="author-keywords"><kwd>Leewenhoekiella blandensis</kwd><kwd>ribonucleotide reductase</kwd><kwd>allosteric regulation</kwd><kwd>dATP inhibition</kwd><kwd>ATP-cone</kwd><kwd>oligomerization</kwd></kwd-group><kwd-group kwd-group-type="research-organism"><title>Research organism</title><kwd>Other</kwd></kwd-group><funding-group><award-group id="fund1"><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/501100002794</institution-id><institution>Cancerfonden</institution></institution-wrap></funding-source><award-id>CAN 721 2016/670</award-id><principal-award-recipient><name><surname>Sjöberg</surname><given-names>Britt-Marie</given-names></name></principal-award-recipient></award-group><award-group id="fund2"><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/501100004359</institution-id><institution>Vetenskapsrådet</institution></institution-wrap></funding-source><award-id>2016-01920,2016-04855,621-2014-5670</award-id><principal-award-recipient><name><surname>Berggren</surname><given-names>Gustav</given-names></name><name><surname>Logan</surname><given-names>Derek</given-names></name><name><surname>Sjöberg</surname><given-names>Britt-Marie</given-names></name></principal-award-recipient></award-group><award-group id="fund3"><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/100001388</institution-id><institution>Wenner-Gren Foundation</institution></institution-wrap></funding-source><principal-award-recipient><name><surname>Sjöberg</surname><given-names>Britt-Marie</given-names></name></principal-award-recipient></award-group><award-group id="fund4"><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/501100002805</institution-id><institution>Carl Tryggers Stiftelse för Vetenskaplig Forskning</institution></institution-wrap></funding-source><principal-award-recipient><name><surname>Hofer</surname><given-names>Anders</given-names></name></principal-award-recipient></award-group><award-group id="fund5"><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/501100001862</institution-id><institution>Svenska Forskningsrådet Formas</institution></institution-wrap></funding-source><award-id>213-2014-880</award-id><principal-award-recipient><name><surname>Berggren</surname><given-names>Gustav</given-names></name></principal-award-recipient></award-group><award-group id="fund6"><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/100010663</institution-id><institution>H2020 European Research Council</institution></institution-wrap></funding-source><award-id>714102</award-id><principal-award-recipient><name><surname>Berggren</surname><given-names>Gustav</given-names></name></principal-award-recipient></award-group><funding-statement>The funders had no role in study design, data collection and interpretation, or the decision to submit the work for publication.</funding-statement></funding-group><custom-meta-group><custom-meta specific-use="meta-only"><meta-name>Author impact statement</meta-name><meta-value>Structural and functional characterization of an unanticipated mode of allosteric activity regulation in ribonucleotide reductases controlled by an ATP-cone in the radical-generating subunit.</meta-value></custom-meta></custom-meta-group></article-meta></front><body><sec id="s1" sec-type="intro"><title>Introduction</title><p>Allosteric regulation of an enzyme is defined as regulation of activity by binding of an effector molecule to a different location of the enzyme than the active site. The effector influences the distribution of tertiary or quaternary conformations of an enzyme, alone or in combination, modulating its activity (<xref ref-type="bibr" rid="bib61">Swain and Gierasch, 2006</xref>). Allostery is an intrinsic property of many, if not all, dynamic proteins (<xref ref-type="bibr" rid="bib31">Gunasekaran et al., 2004</xref>) and an important factor in disease (<xref ref-type="bibr" rid="bib51">Nussinov and Tsai, 2013</xref>), and has hence attracted considerable scientific interest. A substantial part of this interest has been focused on ribonucleotide reductase (RNR), which has been termed a ‘paradigm for allosteric regulation of enzymes’ (<xref ref-type="bibr" rid="bib6">Aravind et al., 2000</xref>).</p><p>RNRs are essential enzymes in all free-living cells, providing the only known de novo pathway for the biosynthesis of deoxyribonucleotides (dNTPs), the immediate precursors for DNA synthesis and repair (<xref ref-type="bibr" rid="bib32">Hofer et al., 2012</xref>; <xref ref-type="bibr" rid="bib50">Nordlund and Reichard, 2006</xref>). To avoid imbalanced levels of dNTPs and the increased mutation rates that are the inevitable consequences of this (<xref ref-type="bibr" rid="bib41">Kumar et al., 2011</xref>; <xref ref-type="bibr" rid="bib45">Mathews, 2006</xref>; <xref ref-type="bibr" rid="bib68">Watt et al., 2016</xref>), RNRs are tightly controlled through transcriptional and allosteric regulation, subcellular compartmentalization and small protein inhibitors (<xref ref-type="bibr" rid="bib52">Pai and Kearsey, 2017</xref>; <xref ref-type="bibr" rid="bib66">Torrents, 2014</xref>). Allosteric regulation of RNRs affects both substrate specificity and overall activity. The specificity regulation has been intensively studied and described for all three classes of RNRs (<xref ref-type="bibr" rid="bib2">Andersson et al., 2000</xref>; <xref ref-type="bibr" rid="bib32">Hofer et al., 2012</xref>; <xref ref-type="bibr" rid="bib43">Larsson et al., 2004</xref>; <xref ref-type="bibr" rid="bib55">Reichard, 2010</xref>; <xref ref-type="bibr" rid="bib64">Torrents et al., 2000</xref>; <xref ref-type="bibr" rid="bib74">Zimanyi et al., 2016</xref>). The s-site binds dNTPs and determines which nucleotide will be reduced at the active site to ensure balanced levels of the four dNTPs in the cell. Additionally, many RNRs possess an overall activity regulation site (a-site) (<xref ref-type="bibr" rid="bib12">Brown and Reichard, 1969</xref>; <xref ref-type="bibr" rid="bib62">Thelander and Reichard, 1979</xref>) positioned in an N-terminal domain of ~85–100 amino acid residues called the ATP-cone (<xref ref-type="bibr" rid="bib6">Aravind et al., 2000</xref>; <xref ref-type="bibr" rid="bib24">Eriksson et al., 1997</xref>). Acting as a regulatory master switch, the a-site senses intracellular nucleotide concentrations by competitive binding of ATP and dATP. In the presence of ATP the enzyme is active, and when concentrations of dNTPs rise, binding of dATP switches the enzyme off. This mechanism ensures sufficient but not excessive amounts of nucleotides that may also cause increased mutation rates (<xref ref-type="bibr" rid="bib45">Mathews, 2006</xref>).</p><p>The ATP-cone is an example of allosteric regulation controlled by a domain that acts relatively independent of the catalytic core of proteins. This type of allosteric regulation has been shown to provide an evolutionarily dynamic process by which allosteric regulation can be lost or gained both in RNRs (<xref ref-type="bibr" rid="bib44">Lundin et al., 2015</xref>) and other enzymes (<xref ref-type="bibr" rid="bib5">Aravind and Koonin, 1999</xref>; <xref ref-type="bibr" rid="bib42">Lang et al., 2014</xref>). Although regulation has been lost and gained repeatedly in RNRs through evolutionary time, to date, the ATP-cone domain has been observed exclusively at the N-terminus of the catalytic subunit NrdA (class I), NrdJ (class II) and NrdD (class III). Class I RNRs consist of a large, catalytic subunit (α or NrdA), and a smaller, radical-generating subunit (β or NrdB) (<xref ref-type="bibr" rid="bib34">Huang et al., 2014</xref>; <xref ref-type="bibr" rid="bib50">Nordlund and Reichard, 2006</xref>). NrdA and NrdB interact to form the active complex, in which the two proteins need to be precisely positioned such that the radical can be transferred from NrdB, where it is generated and stored, to NrdA, where it starts the substrate reduction. In class I, it has long been noted that ATP-cones are absent from subclass Ib (NrdE) but present in several, but not all, NrdAs. A recent phylogenetic subclassification of RNRs reveals that three phylogenetically well-supported subclasses of class I never have ATP-cones (<xref ref-type="bibr" rid="bib36">Jonna et al., 2015</xref>) (<ext-link ext-link-type="uri" xlink:href="http://rnrdb.pfitmap.org">http://rnrdb.pfitmap.org</ext-link>): NrdE, NrdAi and NrdAk. In two of these subclasses we instead discovered ATP-cones attached to their corresponding radical-generating subunit: NrdF (the Ib subclass) and NrdBi. It hence appears as if the lack of activity regulation through an ATP-cone in the catalytic subunit is compensated by the presence of this domain in the non-homologous radical-generating subunit of some RNRs.</p><p>Three distinct types of class I complexes have been mechanistically characterized and found to operate via nucleotide-induced regulation of quaternary structure (<xref ref-type="bibr" rid="bib35">Johansson et al., 2016</xref>; <xref ref-type="bibr" rid="bib36">Jonna et al., 2015</xref>; <xref ref-type="bibr" rid="bib39">Kashlan et al., 2002</xref>; <xref ref-type="bibr" rid="bib56">Rofougaran et al., 2008</xref>; <xref ref-type="bibr" rid="bib57">Rofougaran et al., 2006</xref>; <xref ref-type="bibr" rid="bib65">Torrents et al., 2006</xref>). Crystal structures, cryo-electron microscopy reconstructions and small-angle X-ray scattering studies of inhibited complexes have revealed that when dATP is bound at the a-site, high molecular mass oligomers are formed, in which the radical transfer pathway is distorted (<xref ref-type="bibr" rid="bib3">Ando et al., 2011</xref>; <xref ref-type="bibr" rid="bib4">Ando et al., 2016</xref>; <xref ref-type="bibr" rid="bib26">Fairman et al., 2011</xref>; <xref ref-type="bibr" rid="bib35">Johansson et al., 2016</xref>). Conversely, when ATP is bound, an active enzyme complex is formed. Interestingly, the structure and organization of subunits in active and inactive complexes varies considerably between species (<xref ref-type="bibr" rid="bib1">Ahmad and Dealwis, 2013</xref>; <xref ref-type="bibr" rid="bib32">Hofer et al., 2012</xref>). In <italic>Escherichia coli</italic> RNR, the active NrdAB complex is α<sub>2</sub>β<sub>2</sub>, whereas the inactive form is an α<sub>4</sub>β<sub>4</sub> ring-shaped octamer where the ATP-cones in the α subunits sequester the β subunits in a non-productive conformation (<xref ref-type="bibr" rid="bib3">Ando et al., 2011</xref>). In the eukaryotic class I RNR, the inactive complex differs from the one in <italic>E. coli</italic> in that it has an α<sub>6</sub> stoichiometry. This hexamer can only bind one β<sub>2</sub> subunit in an unproductive manner without a properly aligned electron transport chain (<xref ref-type="bibr" rid="bib26">Fairman et al., 2011</xref>). Activation by ATP creates a different type of α<sub>6</sub> complex that binds one or more β<sub>2</sub> complexes (<xref ref-type="bibr" rid="bib4">Ando et al., 2016</xref>; <xref ref-type="bibr" rid="bib9">Aye and Stubbe, 2011</xref>; <xref ref-type="bibr" rid="bib18">Crona et al., 2013</xref>; <xref ref-type="bibr" rid="bib26">Fairman et al., 2011</xref>; <xref ref-type="bibr" rid="bib57">Rofougaran et al., 2006</xref>). The different complexes are formed by subtle changes at the a-site induced by binding of the different nucleotides (<xref ref-type="bibr" rid="bib26">Fairman et al., 2011</xref>; <xref ref-type="bibr" rid="bib72">Xu et al., 2006</xref>). Another oligomerization mechanism has been recently found in <italic>Pseudomonas aeruginosa</italic> class I RNR, which possesses two consecutive ATP-cones, of which only the N-terminal one binds nucleotides. The active complex is once again α<sub>2</sub>β<sub>2</sub>, but the inactive <italic>P. aeruginosa</italic> RNR complex is a dATP-induced α<sub>4</sub> complex consisting of a ring of four α subunits interacting via their outer ATP-cones (<xref ref-type="bibr" rid="bib35">Johansson et al., 2016</xref>; <xref ref-type="bibr" rid="bib36">Jonna et al., 2015</xref>). A single β<sub>2</sub> can bind to this ring, but the complex is inactive. Oligomerization of RNRs may be a useful character to explore biomedically. RNRs have long attracted interest as potential targets for novel antibiotics as well as for cancer therapy (<xref ref-type="bibr" rid="bib8">Aye et al., 2015</xref>; <xref ref-type="bibr" rid="bib37">Julián et al., 2015</xref>; <xref ref-type="bibr" rid="bib63">Tholander and Sjöberg, 2012</xref>). Several RNR drugs are directed towards the radical-containing subunit and the active site of the catalytic subunit. Recently, some nucleoside analogs used in cancer treatments and known to inhibit RNRs in vitro in their phosphorylated forms were shown to induce hexameric complexes in vivo (<xref ref-type="bibr" rid="bib7">Aye et al., 2012</xref>; <xref ref-type="bibr" rid="bib9">Aye and Stubbe, 2011</xref>; <xref ref-type="bibr" rid="bib71">Wisitpitthaya et al., 2016</xref>).</p><p>The unexpected finding of an ATP-cone fused to the radical-generating subunits poses questions regarding how it might regulate activity. Here we describe the mechanism of activity regulation by the ATP-cone N-terminally fused to the radical-generating NrdBi from <italic>Leeuwenhoekiella blandensis</italic> sp. nov. strain MED217. <italic>L. blandensis</italic> was isolated from Mediterranean surface seawater and belongs to Flavobacteriaceae, the major family of marine Bacteroidetes, with important roles in carbon flow and nutrient turnover in the sea during and following algal blooms (<xref ref-type="bibr" rid="bib27">Fernández-Gómez et al., 2013</xref>; <xref ref-type="bibr" rid="bib53">Pinhassi et al., 2006</xref>). <italic>L. blandensis</italic> possesses two RNRs: a class II without ATP-cone, and the class I NrdAi/NrdBi, which lacks an ATP-cone in NrdA and instead contains an ATP-cone positioned at the N-terminus of NrdB. Superficially, the allosteric mechanism of <italic>L. blandensis</italic> NrdAi/NrdBi holoenzyme is similar to when the ATP-cone is contained in the catalytic subunit. At high dATP concentrations, inhibited higher oligomeric complexes of the holoenzyme are favoured. However, in the <italic>L. blandensis</italic> class I RNR, the oligomerization is driven by a shift towards tetramers of the radical-generating subunit. This illustrates how allosteric regulation controlled by ATP-cones can evolve in a highly dynamic way, requiring few adaptations to the core of the enzyme. The relative ease by which ATP-cone-driven activity regulation appears to evolve, provides a potential route to regulate engineered enzymes by dATP-inhibition for enzymes in which activity is affected by oligomerization. Addition of an ATP-cone to the protein could be used to induce higher oligomers controlled by dATP addition.</p></sec><sec id="s2" sec-type="results"><title>Results</title><sec id="s2-1"><title>The activity allosteric regulatory ATP-cone is linked to the radical-containing subunit in some class I RNRs</title><p>We detected ATP-cones in the radical-generating subunits of RNRs from two distinct phylogenetic RNR subclasses: NrdBi and NrdF (<xref ref-type="fig" rid="fig1">Figure 1a</xref>). In the NrdBi sequences, the ATP-cone was found at the N-terminus of the protein, whereas it was found at the C-terminus of the NrdF proteins (<xref ref-type="fig" rid="fig1">Figure 1b</xref>). Interestingly, the corresponding catalytic subunit subclasses – NrdAi and NrdE respectively – have been found to lack ATP-cones. Ninety-three sequences in NCBI’s RefSeq database are NrdBi proteins with N-terminally positioned ATP-cones. They are encoded by viruses and bacteria from several phyla, although the Flavobacteriales order in the Bacteroidetes phylum predominate (70 sequences, <ext-link ext-link-type="uri" xlink:href="http://rnrdb.pfitmap.org">http://rnrdb.pfitmap.org</ext-link>). NrdF proteins with a C-terminally positioned ATP-cone are only encoded by a few species of the Meiothermus genus of the Deinococcus-Thermus phylum (<ext-link ext-link-type="uri" xlink:href="http://rnrdb.pfitmap.org">http://rnrdb.pfitmap.org</ext-link>). All species encoding NrdB proteins with ATP-cones in their genomes also encode other RNRs.</p><fig id="fig1" position="float"><object-id pub-id-type="doi">10.7554/eLife.31529.003</object-id><label>Figure 1.</label><caption><title>Unrooted phylogenetic tree of NrdB sequences and genome arrangements of NrdB sequences with ATP-cones.</title><p>(<bold>a</bold>) Maximum likelihood phylogeny of class I RNR radical generating subunit with subclasses in color, names to the left and organism distributions to the right (see inset legend; sizes of circles are proportional to the number of sequences found in each taxon). Bootstrap support values greater than 0.7 are shown with colored diamonds. NrdBs with ATP-cones were discovered in two subclasses: NrdBi and NrdF (formerly class Ib). Neither of the two subclasses have corresponding catalytic subunits, NrdAi and NrdE respectively, with ATP-cones. In both subclasses, NrdB sequences with ATP-cones were rare and phylogenetically limited, see inset arrows. (<bold>b</bold>) Arrangement of class I RNR genes in three genomes encoding NrdB proteins with ATP-cones (<italic>green borders</italic>, NrdAi/NrdBi; <italic>purple borders</italic>, NrdE/NrdF). Genes are shown 5’ to 3’, so that ATP-cones in the N-terminus are to the left in the gene.</p></caption><graphic mime-subtype="postscript" mimetype="application" xlink:href="elife-31529-fig1-v1"/></fig></sec><sec id="s2-2"><title>Substrate specificity regulation of <italic>L. blandensis</italic> RNR via the s-site</title><p>Initially we cloned, expressed and purified the <italic>L. blandensis</italic> NrdBi and NrdAi proteins. Using a four-substrate activity assay in the presence of saturating concentrations of the s-site effectors dTTP, dGTP or ATP, we found that <italic>L. blandensis</italic> RNR has a similar specificity regulation pattern to most characterized RNRs (<xref ref-type="bibr" rid="bib32">Hofer et al., 2012</xref>). ATP stimulated the reduction of CDP and UDP, whereas dTTP stimulated the reduction of GDP, and dGTP stimulated the reduction of ADP and GDP (<xref ref-type="fig" rid="fig2">Figure 2</xref>). The enzyme was completely inactive in the absence of allosteric effectors. Using mixtures of allosteric effectors, we observed that dTTP-induced GDP reduction dramatically increased in the presence of ATP (<xref ref-type="fig" rid="fig2">Figure 2</xref>).</p><fig id="fig2" position="float"><object-id pub-id-type="doi">10.7554/eLife.31529.004</object-id><label>Figure 2.</label><caption><title>Allosteric specificity regulation of the <italic>L. blandensis</italic> class I RNR.</title><p>Enzyme activity was measured after 10 and 30 min in the presence of all four substrates (0.5 mM each) and with the indicated allosteric effectors (2 mM of each). Error bars indicate the extremes of two measurements. Protein concentrations were 1 µM NrdB and 4 µM NrdA.</p></caption><graphic mime-subtype="x-tiff" mimetype="image" xlink:href="elife-31529-fig2-v1"/></fig></sec><sec id="s2-3"><title>Overall activity of <italic>L. Blandensis</italic> RNR is regulated via the NrdB-linked ATP-cone</title><p>We performed a series of activity assays with CDP as substrate to elucidate the potential roles of ATP and dATP in activating and inhibiting the enzyme (<xref ref-type="fig" rid="fig3">Figure 3</xref>). The presence of ATP clearly activated the enzyme (<xref ref-type="fig" rid="fig3">Figure 3a</xref>), while dATP activated the enzyme when used at low concentrations and was inhibitory at 30 µM and higher (<xref ref-type="fig" rid="fig3">Figure 3b</xref>). An ATP-cone deletion mutant NrdB∆99, lacking the N-terminal 99 residues, reached a lower maximum activity compared to the wild type enzyme, suggesting that it was not activated by ATP beyond saturation of the s-site in the NrdA, nor was it inhibited by dATP (<xref ref-type="fig" rid="fig3">Figure 3a–b</xref>). From the NrdB∆99 effector titrations, we could calculate K<sub>L</sub> values – the concentrations of allosteric effectors that give half maximal enzyme activity – for binding of ATP and dATP to the s-site in NrdA to 30 and 1.4 μM respectively. Titration of ATP into wild type NrdB in the presence of an excess of NrdA saturated with dTTP showed that it activates the enzyme through the a-site with a K<sub>L</sub> of 96 μM (<xref ref-type="fig" rid="fig3">Figure 3c</xref>). For the corresponding inhibition by dATP binding to the a-site, we calculated the K<sub>i</sub> value - the binding constant of a non-competitive inhibitor - to be 20 µM in the presence of an s-site saturating dTTP concentration (<xref ref-type="fig" rid="fig3">Figure 3d</xref>). We also tested if only the triphosphate form of (deoxy)adenosine nucleotides would interact with the a-site in presence of s-site saturating dTTP concentrations. In addition to ATP and dATP, dADP was also found to interact, whereas ADP, AMP and dAMP had no effect (<xref ref-type="fig" rid="fig3">Figure 3e</xref>). Titration with dADP inhibited the enzyme activity, although less strongly than dATP (<xref ref-type="fig" rid="fig3">Figure 3f</xref>).</p><fig id="fig3" position="float"><object-id pub-id-type="doi">10.7554/eLife.31529.005</object-id><label>Figure 3.</label><caption><title>Activity of <italic>L. blandensis</italic> RNR with wild type NrdB or NrdB∆99 in the presence of allosteric effectors.</title><p>NrdB was used in excess over NrdA when studying the s-site and NrdA was used in excess when studying the a-site. (<bold>a–b</bold>) CDP reduction assayed in mixtures of 0.5 µM NrdA and 2 µM of either wild type NrdB (black circles) or NrdB∆99 (white circles), titrated with ATP (<bold>a</bold>) or dATP (<bold>b</bold>). (<bold>c</bold>) GDP reduction assay mixtures with 2 µM NrdA and 0.5 µM wild type NrdB titrated with ATP in the presence of an s-site saturating concentration of dTTP (2 mM). (<bold>d</bold>) Reduction of GDP assayed with 2 µM NrdA and 0.5 µM wild type NrdB, titrated with dATP in the presence of an s-site saturating concentration of dTTP (2 mM). (<bold>e</bold>) GDP reduction in presence of s-site saturating dTTP (2 mM) and 2 mM of the indicated adenosine nucleotides. Assay mixtures contained 4 µM NrdA and 1 µM NrdB. 100% activity corresponded to 639 nmol x mg<sup>−1</sup> x min<sup>−1</sup>. (<bold>f</bold>) CDP reduction assays titrated with dADP. Assay mixtures contained 2 µM NrdA and 0.5 µM NrdB. Error bars in panels E and F indicate the standard deviation of three measurements.</p></caption><graphic mime-subtype="x-tiff" mimetype="image" xlink:href="elife-31529-fig3-v1"/></fig></sec><sec id="s2-4"><title>dATP binding to NrdB induces formation of higher oligomeric complexes</title><p>To elucidate the mechanism of allosteric overall activity regulation governed by the NrdB-linked ATP-cone, activity-independent oligomer-distribution experiments were performed by gas-phase electrophoretic macromolecule analysis (GEMMA). In the absence of allosteric effectors, NrdB (β) is mainly monomeric (theoretically 51.8 kDa) and, in contrast to most studied NrdB proteins, it does not readily form dimers at the low protein concentration range suitable for GEMMA analyses (<xref ref-type="fig" rid="fig4">Figure 4a</xref>). Addition of dATP (50 μM) dramatically shifted the equilibrium towards tetramers β<sub>4</sub>, which became the major form under these conditions (<xref ref-type="fig" rid="fig4">Figure 4a</xref>). Titration of increasing concentrations of dATP to NrdB showed that the tetramers reached their half-maximum mass concentration at around 10 µM dATP (<xref ref-type="fig" rid="fig4s1">Figure 4—figure supplement 1</xref>). Addition of 50 μM dADP also induced formation of NrdB tetramers, although less efficiently than with dATP (<xref ref-type="fig" rid="fig4">Figure 4a</xref>). In contrast, the NrdB∆99 mutant, lacking the ATP-cone (<xref ref-type="fig" rid="fig4">Figure 4b</xref>), was mainly monomeric regardless if dATP was present or not (<xref ref-type="fig" rid="fig4">Figure 4b</xref>), demonstrating that the NrdB-linked ATP-cone is required for dATP-induced tetramer formation. The protein had a tendency to aggregate, which can possibly explain the ladder of monomers, dimers, trimers and tetramers. NrdA was a monomer (theoretically 70.6 kDa) in the absence of allosteric effectors, while addition of dATP prompted formation of dimers (<xref ref-type="fig" rid="fig4">Figure 4c</xref>) To assess the oligomeric state of the complete enzymatic complex of the inactive <italic>L. blandensis</italic> RNR, a mixture of NrdA (α) and NrdB (β) in the presence of 100 µM dATP was analyzed with GEMMA (<xref ref-type="fig" rid="fig4">Figure 4c</xref>). The two subunits formed a large complex of 340 kDa with the expected mass of an α<sub>2</sub>β<sub>4</sub> complex (theoretically 348 kDa), and at higher protein concentration a complex of 465 kDa with the expected mass of an α<sub>4</sub>β<sub>4</sub> complex (theoretically 488 kDa) started to appear.</p><fig-group><fig id="fig4" position="float"><object-id pub-id-type="doi">10.7554/eLife.31529.006</object-id><label>Figure 4.</label><caption><title>GEMMA analysis of the <italic>L. blandensis</italic> RNR subunits α, β and their combinations in the presence and the absence of allosteric effectors.</title><p>(<bold>a</bold>) 0.1 mg/ml NrdB (~2 µM) analyzed in the absence and presence of 50 µM dATP or dADP. (<bold>b</bold>) The NrdB∆99 mutant analyzed in the absence and the presence of 50 µM dATP. (<bold>c</bold>) In the top two traces 0.1 mg/ml NrdA (~1.4 µM) is analyzed in the absence or presence of 100 µM dATP. In the third trace, 0.1 mg/ml NrdB is added to the mixture. The last trace is similar to the third trace, but the concentration of NrdA and NrdB is increased to 0.4 mg/ml NrdA and 0.3 mg/ml NrdB (~6 µM of each). The analyses of NrdA-NrdB complexes were performed at a very low pressure (1.4 Psi) to avoid the influence of magnesium-nucleotide clusters on the measurement and to minimize the risk of false protein-protein interactions. The baselines of the individual experiments are distributed in the vertical direction to be able to fit many traces in each panel.</p></caption><graphic mime-subtype="postscript" mimetype="application" xlink:href="elife-31529-fig4-v1"/></fig><fig id="fig4s1" position="float" specific-use="child-fig"><object-id pub-id-type="doi">10.7554/eLife.31529.007</object-id><label>Figure 4—figure supplement 1.</label><caption><title>GEMMA measurements showing the dependence of NrdB tetramerization on the dATP concentration.</title><p>The indicated concentrations are in µM and the measurements were performed at reduced pressure (2 Psi) to minimize the formation of Mg<sup>2+</sup>-dATP clusters (salt peak in the lower traces). The shift of the β peak is due to bound salt clusters (larger particles is much less affected). At dATP concentrations below 80 µM, the effect of salt clusters on the measurements became negligible. The measurement was performed with 0.5 mg/ml NrdB (~1 μM). The traces are distributed in the vertical direction to fit many experiments in the same panel.</p></caption><graphic mime-subtype="postscript" mimetype="application" xlink:href="elife-31529-fig4-figsupp1-v1"/></fig></fig-group><p>To complement the GEMMA analyses of oligomer formation, we performed analytical size exclusion chromatography (SEC) using higher protein concentrations and physiologically reasonable concentrations of effectors (3 mM ATP and 0.1 to 0.5 mM dATP) (<xref ref-type="bibr" rid="bib10">Bochner and Ames, 1982</xref>; <xref ref-type="bibr" rid="bib13">Buckstein et al., 2008</xref>) on an analytical Superdex 200 PC 3.2/30 column at 7°C (<xref ref-type="fig" rid="fig5">Figure 5</xref>). These experiments were complemented with SEC experiments at room temperature with a semi-preparative column (Superdex 200 10/300 GL) that gave better resolution but was less practical for the bulk experiments due to its much higher mobile phase consumption. The SEC experiments showed that NrdB was in a monomer-dimer-tetramer equilibrium (<xref ref-type="fig" rid="fig5s1">Figure 5—figure supplement 1a</xref>) with an average size comparable to dimers (<xref ref-type="fig" rid="fig5">Figure 5a</xref>). Similar to the results with GEMMA, it was mainly a monomer at lower protein concentrations (<xref ref-type="fig" rid="fig5s1">Figure 5—figure supplement 1a</xref>). ATP and dATP promoted the equilibrium to shift to dimers and tetramers, respectively (<xref ref-type="fig" rid="fig5">Figure 5a</xref>, <xref ref-type="fig" rid="fig5s1">Figure 5—figure supplement 1b</xref>). Without effectors, NrdA was mainly in a monomeric state, while it was dominated by dimers in the presence of either of the two effectors (<xref ref-type="fig" rid="fig5">Figure 5b</xref>). However, in agreement with the GEMMA results the formation of the nucleotide-induced dimer was much less efficient at lower protein concentration (<xref ref-type="fig" rid="fig5s1">Figure 5—figure supplement 1c</xref>). When NrdA and NrdB were mixed in the absence of allosteric effectors, no complex was visible. After addition of ATP, a new complex of ~200 kDa appeared (<xref ref-type="fig" rid="fig5">Figure 5c</xref>). To verify its composition and stoichiometry, we analyzed fractions eluted from SEC on SDS PAGE. Both NrdA and NrdB were visible on the gel in a 1:1 molar ratio (<xref ref-type="fig" rid="fig5">Figure 5c</xref> insert). This complex, formed in conditions promoting active RNR, is conceivably an α<sub>2</sub>β<sub>2</sub> complex. After addition of the inhibiting effector dATP, a complex with a molecular mass consistent with α<sub>4</sub>β<sub>4</sub> eluted. Typical for complexes that equilibrate between each other faster than the time of analysis, a titration using increasing concentrations of NrdA-NrdB mixtures in the presence of 100 μM dATP showed a gradual movement of the NrdB tetramer peak to the left up to the position of an α<sub>4</sub>β<sub>4</sub> complex rather than showing distinct β<sub>4</sub>, α<sub>2</sub>β<sub>4</sub> and α<sub>4</sub>β<sub>4</sub> peaks (<xref ref-type="fig" rid="fig5s1">Figure 5—figure supplement 1d</xref>).</p><fig-group><fig id="fig5" position="float"><object-id pub-id-type="doi">10.7554/eLife.31529.008</object-id><label>Figure 5.</label><caption><title>Size exclusion chromatography of <italic>L. blandensis</italic> RNR in the absence and presence of 3 mM ATP or 0.5 mM dATP.</title><p>Proteins at concentrations of 20 μM each were pre-incubated separately or mixed together for 10 min at room temperature in the absence (black dotted line) or presence of ATP (blue dashed line) or dATP (red solid line), centrifuged and applied to the column equilibrated with SEC buffer at 7°C. Panels show NrdB (<bold>a</bold>), NrdA (<bold>b</bold>), and an equimolar mixture of NrdA and NrdB (<bold>c</bold>). C Insert: SDS PAGE of the eluted proteins run in the presence and absence of the indicated effectors. Elution positions of fractions applied to gel are indicated by <italic>red</italic> (in the presence of dATP) and <italic>blue</italic> (in the presence of ATP) arrows, respectively. (<bold>d</bold>) Summary of multiple SEC experiments varying protein concentrations of NrdA (10–113 μM), NrdB (5–150 μM) and mixtures of NrdA and NrdB at ratios of 1:1 or 1:2. Molecular masses and standard deviations are calculated for 3–5 experiments, and closest estimated complex stoichiometry are shown in parenthesis, with major species underlined when appropriate (see <xref ref-type="fig" rid="fig5s1">Figure 5—figure supplement 1</xref> for details).</p></caption><graphic mime-subtype="x-tiff" mimetype="image" xlink:href="elife-31529-fig5-v1"/></fig><fig id="fig5s1" position="float" specific-use="child-fig"><object-id pub-id-type="doi">10.7554/eLife.31529.009</object-id><label>Figure 5—figure supplement 1.</label><caption><title>Size exclusion chromatography studies of the <italic>L. blandensis</italic> NrdA and NrdB at low protein concentration.</title><p>(<bold>a</bold>) NrdB analyzed at different protein concentrations (in µM) shows that the protein gradually changes from monomers to dimers and to some extent tetramers. (<bold>b</bold>) NrdA analyzed in the presence of 100 µM dATP gradually changes from monomers to dimers when the protein concentration increases. At the intermediate protein concentrations, the protein peak is between monomers and dimers due to the equilibration between the two forms. (<bold>c</bold>) NrdB (10 µM) forms a tetramer in the presence of 100 µM dATP, dimer in the presence of ATP and a mixture of monomers, dimers and tetramers in the absence of allosteric effectors. The experiment without allosteric effectors is the same as the top spectrum in (<bold>a</bold>). (<bold>d</bold>) Mixtures of NrdA and NrdB were analyzed at different protein concentrations (5, 10, 20 and 30 µM of each subunit) in the presence of 100 µM dATP. The experiments were performed on a Superdex 200 10/300 GL column (GE Health Care) at room temperature with a running buffer consisting of 150 mM KCl, 10 mM MgCl<sub>2</sub> and 50 mM Tris-HCl pH 7.6. The KCl concentration was kept at 150 mM except in (<bold>d</bold>), where the concentration needed to be reduced to 50 mM to avoid inhibition of the NrdA-NrdB interaction.</p></caption><graphic mime-subtype="postscript" mimetype="application" xlink:href="elife-31529-fig5-figsupp1-v1"/></fig></fig-group></sec><sec id="s2-5"><title>Three-dimensional structure of <italic>L. blandensis</italic> NrdB</title><p>The crystal structure of the dATP-inhibited complex of <italic>L. blandensis</italic> NrdB at 2.45 Å resolution (PDB 5OLK) revealed a novel tetrameric arrangement hitherto not observed in the RNR family, with approximate 222 point symmetry (<xref ref-type="fig" rid="fig6">Figure 6a</xref>, <xref ref-type="table" rid="table1">Table 1</xref>). Each monomer consists of an ATP-cone domain (residues 1–103) joined by a short linker (104-106) to a metal-binding α-helical core domain (residues 107–398) and a disordered C-terminus (399-427). The latter two features are typical of the NrdB/F family. This domain arrangement gives the NrdB monomer and dimer extended conformations that are presumably flexible in solution (<xref ref-type="fig" rid="fig6">Figure 6b</xref>). The dimer buries about 1100 Å<sup>2</sup> of solvent accessible area on each monomer. The tetrameric arrangement is completely dependent on interactions between the ATP cone domains, as no contacts are made between the core domains in the two dimers that make up the tetramer (<xref ref-type="fig" rid="fig6">Figure 6a</xref>).</p><fig-group><fig id="fig6" position="float"><object-id pub-id-type="doi">10.7554/eLife.31529.010</object-id><label>Figure 6.</label><caption><title>Structure of tetrameric <italic>L. blandensis</italic> NrdB in complex with dATP.</title><p>(<bold>a</bold>) Overall structure of the NrdB tetramer. The two monomers of each dimer are colored in different shades of gray, while the N-terminal ATP-cones are colored orange and light blue respectively. The dATP molecules are shown in CPK representation. The curved lines at the top and bottom of each dimer core indicate the proposed binding area in the active α<sub>2</sub>β<sub>2</sub> complex of RNRs. (<bold>b</bold>) Surface representation of an NrdB dimer extracted from the tetramer structure, showing the presumably flexible nature of the ATP-cones in solution. The color scheme is as in panel a). (<bold>c</bold>) Binding of two dATP molecules to the ATP-cone. The dATP molecules are shown as sticks. Residues involved in binding the two dATP molecules are labeled in blue and red respectively. Polar contacts are shown as dotted yellow lines. (<bold>d</bold>) The interface between ATP-cones in the NrdB tetramer. Chains A and D are shown in light blue and orange respectively. Side chains of residues involved in the interface are labeled. The two dATP molecules closest to the interface are shown as sticks. Polar contacts are shown as yellow dotted lines. (<bold>e</bold>) Structure of the metal site in chain C, which is representative of the others. Metal ions are shown as purple spheres. 2 m|Fo|-D|Fc| electron density is shown as a grey mesh, contoured at 1.4 σ. Asn m|Fo|-D|Fc| OMIT map for the metal ions is shown in purple, contoured at 4.0 σ.</p><p><supplementary-material id="fig6sdata1"><object-id pub-id-type="doi">10.7554/eLife.31529.014</object-id><label>Figure 6—source data 1.</label><caption><title>Data quality statistics for the anomalous data used for metal identification.</title><p>Figures in parentheses are for the highest resolution shell.</p></caption><media mime-subtype="docx" mimetype="application" xlink:href="elife-31529-fig6-data1-v1.docx"/></supplementary-material></p><p><supplementary-material id="fig6sdata2"><object-id pub-id-type="doi">10.7554/eLife.31529.015</object-id><label>Figure 6—source data 2.</label><caption><title>Peak heights of metal ions in anomalous difference maps calculated at three different wavelengths after refining the same structure against data at each wavelength.</title><p>The peak heights are given in standard deviations above the mean. For reference, the anomalous difference map peak heights are also given for two of the most well-ordered sulfur atoms in the structure, in Met A80 and Met D32. It can be seen that the average peak heights for the metal ions vary little with wavelength and are at most only about twice the height of those for the sulfur atoms, which is most consistent with them being Ca<sup>2+</sup>, whose f’ component is about twice that of sulfur at all three wavelengths, whereas that of Mn<sup>2+</sup> or Fe<sup>2+/3+</sup> is more than four times higher at 1.72 Å and 1.87 Å.</p></caption><media mime-subtype="docx" mimetype="application" xlink:href="elife-31529-fig6-data2-v1.docx"/></supplementary-material></p></caption><graphic mime-subtype="x-tiff" mimetype="image" xlink:href="elife-31529-fig6-v1"/></fig><fig id="fig6s1" position="float" specific-use="child-fig"><object-id pub-id-type="doi">10.7554/eLife.31529.011</object-id><label>Figure 6—figure supplement 1.</label><caption><title>The ligands of the metal center in the four non-crystallographically related monomers of <italic>L. blandensis</italic> NrdB.</title><p>The metal ions are shown as small purple spheres and the ligands as sticks. Coordination distances are shown by yellow dotted lines and the metal-to-metal distances are shown as black dotted lines. Two water molecules are shown, one coordinated to the right-hand metal and one that is consistently found in all centers but which is outside of coordination distance.</p></caption><graphic mime-subtype="x-tiff" mimetype="image" xlink:href="elife-31529-fig6-figsupp1-v1"/></fig><fig id="fig6s2" position="float" specific-use="child-fig"><object-id pub-id-type="doi">10.7554/eLife.31529.012</object-id><label>Figure 6—figure supplement 2.</label><caption><title>NrdBi HMMER sequence profile logo.</title><p>Residues discussed in the results are marked in the figure with numbering according to <italic>L. blandensis</italic> NrdBi. Letter heights are proportional to probabilities for each amino acid at a given position, disregarding background probabilities. Total height of letters is proportional to information content in a given position. Generated with Skylign(<xref ref-type="bibr" rid="bib69">Wheeler et al., 2014</xref>).</p></caption><graphic mime-subtype="x-tiff" mimetype="image" xlink:href="elife-31529-fig6-figsupp2-v1"/></fig><fig id="fig6s3" position="float" specific-use="child-fig"><object-id pub-id-type="doi">10.7554/eLife.31529.013</object-id><label>Figure 6—figure supplement 3.</label><caption><title>Distortion of the first helix of the metal-coordinating 4-helix bundle in <italic>L. blandensis</italic> NrdB.</title><p>The structure of <italic>E. coli</italic> NrdB (represented by PDB entry 2XOF) was superimposed using all Cα atoms in the same monomer. <italic>L. blandensis</italic> NrdB is shown as a gray cartoon with the metal coordinating side chains, as well as those of Tyr207 and all residues from 171 to 176 shown as sticks. Metal ions are shown as small purple spheres. For clarity, the cartoon for the second helix of the bundle (containing residues Glu200, His203) is not shown. The corresponding undistorted helix from <italic>E. coli</italic> NrdB is shown as a blue cartoon.</p></caption><graphic mime-subtype="x-tiff" mimetype="image" xlink:href="elife-31529-fig6-figsupp3-v1"/></fig></fig-group><table-wrap id="table1" position="float"><object-id pub-id-type="doi">10.7554/eLife.31529.016</object-id><label>Table 1.</label><caption><title>Data collection and refinement statistics.</title><p>Figures in parentheses are for the highest resolution shell.</p></caption><table frame="hsides" rules="groups"><thead><tr><th valign="top">Wavelength</th><th valign="top">0.9724</th></tr></thead><tbody><tr><td valign="top">Resolution range (Å)</td><td valign="top">44.7–2.45 (2.51–2.45)</td></tr><tr><td valign="top">Space group</td><td valign="top">P1</td></tr><tr><td valign="top">Unit cell (Å, °)</td><td valign="top">a = 74.0, b = 90.5, c = 90.9, α = 110.78, β = 98.99, γ = 114.11</td></tr><tr><td valign="top">Total no. reflections</td><td valign="top">246972 (15753)</td></tr><tr><td valign="top">No. unique reflections</td><td valign="top">67728 (4517)</td></tr><tr><td valign="top">Multiplicity</td><td valign="top">3.6 (3.5)</td></tr><tr><td valign="top">Completeness (%)</td><td valign="top">97.8 (97.3)</td></tr><tr><td valign="top">Mean I/σ(I)</td><td valign="top">7.4 (1.0)</td></tr><tr><td valign="top">Wilson B-factor (Å<sup>2</sup>)</td><td valign="top">63.3</td></tr><tr><td valign="top">R<sub>merge</sub> (I)</td><td valign="top">0.093 (1.058)</td></tr><tr><td valign="top">R<sub>meas</sub> (I)</td><td valign="top">0.109 (1.243)</td></tr><tr><td valign="top">R<sub>pim</sub> (I)</td><td valign="top">0.055 (0.639)</td></tr><tr><td valign="top">CC(½) (I)</td><td valign="top">0.997 (0.495)</td></tr><tr><td valign="top">Reflections used in refinement</td><td valign="top">67723</td></tr><tr><td valign="top">Reflections used for R<sub>free</sub></td><td valign="top">3353 (5%)</td></tr><tr><td valign="top">R<sub>model</sub> (F)</td><td valign="top">0.205 (0.221)</td></tr><tr><td valign="top">R<sub>free</sub> (F)</td><td valign="top">0.238 (0.265)</td></tr><tr><td valign="top">Number of non-hydrogen atoms:</td><td valign="top"/></tr><tr><td valign="top">macromolecules</td><td valign="top">12919</td></tr><tr><td valign="top">ligands</td><td valign="top">284</td></tr><tr><td valign="top">water molecules</td><td valign="top">129</td></tr><tr><td valign="top">rms deviation from ideal geometry (bonds)</td><td valign="top">0.010</td></tr><tr><td valign="top">rms deviation (angles)</td><td valign="top">1.11</td></tr><tr><td valign="top">Ramachandran favored (%)</td><td valign="top">97.7</td></tr><tr><td valign="top">Ramachandran allowed (%)</td><td valign="top">2.1</td></tr><tr><td valign="top">Ramachandran outliers (%)</td><td valign="top">0.2</td></tr><tr><td valign="top">Rotamer outliers (%)</td><td valign="top">3.5</td></tr><tr><td valign="top">Clashscore</td><td valign="top">3.22 (100th percentile)</td></tr><tr><td valign="top">Wilson B-factor (Å<sup>2</sup>)</td><td valign="top">63.3</td></tr><tr><td valign="top">Average B-factors (Å<sup>2</sup>):</td><td valign="top"/></tr><tr><td valign="top">macromolecules</td><td valign="top">66.5</td></tr><tr><td valign="top">ligands</td><td valign="top">69.5</td></tr><tr><td valign="top">solvent</td><td valign="top">54.0</td></tr></tbody></table></table-wrap><p>The ATP-cone domain in <italic>L. blandensis</italic> NrdB is structurally very similar to the one recently identified in the NrdA protein of <italic>P. aeruginosa</italic> (<xref ref-type="bibr" rid="bib35">Johansson et al., 2016</xref>). The root-mean-square deviation for 92 equivalent Cα atoms is 1.2 Å. The electron density unambiguously confirms the <italic>L. blandensis</italic> ATP-cone’s ability to bind two molecules of dATP, which it shares with <italic>P. aeruginosa</italic> NrdA (<xref ref-type="fig" rid="fig6">Figure 6c</xref>). Despite a local sequence identity of only 31% to <italic>P. aeruginosa</italic> NrdA, all amino acids involved in binding both dATP molecules are conserved (<xref ref-type="fig" rid="fig6">Figure 6c</xref>). The two dATP molecules bind in a ‘tail-to-tail’ arrangement that orients the base of the ‘non-canonical’ dATP towards the fourth, most C-terminal helix, an arrangement made possible by the binding of a Mg<sup>2+</sup> ion between the triphosphate moieties.</p><p>Remarkably, the interactions between the ATP-cones in <italic>L. blandensis</italic> NrdB are also very similar to those seen in <italic>P. aeruginosa</italic> NrdA (<xref ref-type="bibr" rid="bib35">Johansson et al., 2016</xref>), despite the fact that the ATP-cone is attached to a structurally completely different core domain. The main interactions occur between the last two helices α3 and α4 in respective ATP-cones (<xref ref-type="fig" rid="fig6">Figure 6d</xref>). A hydrophobic core in <italic>L. blandensis</italic> NrdB involving residues Met80, Ile92 and Ile93 in both monomers is reinforced by salt bridges between residues Asp73, Asp76 in one monomer and Lys89 in the other. The two domains bury ~510 Å<sup>2</sup> of solvent accessible area. This is slightly less than the ~640 Å<sup>2</sup> buried in the equivalent interaction involving the ATP-cones of <italic>P. aeruginosa</italic> NrdA. Within each ATP cone, helices α3 and α4 have the same relative orientation, partly determined by an internal salt bridge between the conserved Asp73 and Arg95, but the helix pair in <italic>L. blandensis</italic> NrdB is rotated relative to its counterpart in the other ATP cone by about 15° compared to <italic>P. aeruginosa</italic> NrdA, which reduces the number of possible interactions between them. Interestingly, the dATP-induced tetramer leaves free the surfaces of both dimers of <italic>L. blandensis</italic> NrdB that are thought to interact with the NrdA subunit in productive RNR complexes, which implies that one or two dimers of <italic>L. blandensis</italic> NrdA could attach to these surfaces in a near-productive fashion in α<sub>2</sub>β<sub>4</sub> or α<sub>4</sub>β<sub>4</sub> complexes (<xref ref-type="fig" rid="fig6">Figure 6a</xref>).</p><p>Two metal ions are found to bind to each of the monomers of <italic>L. blandensis</italic> NrdB. Comparison of their B-factors with those of surrounding atoms suggest that they are fourth row elements with close to full occupancy, but does not enable us to distinguish between Mn, Fe or Ca. No metal ions were added to the protein preparation, but crystals were obtained in 0.2 M CaCl<sub>2</sub>. The distance between metal ions varies between 3.4–3.8 Å in the four monomers (<xref ref-type="fig" rid="fig6s1">Figure 6—figure supplement 1</xref>), but the metal coordination is very similar. The coordination distances are long for an RNR metal center, with the shortest distances being 2.3–2.4 Å, in contrast to the more typical 1.9–2.1 Å seen in other NrdB proteins containing Mn or Fe. Anomalous diffraction at three wavelengths was used to determine the nature of the metal. <xref ref-type="supplementary-material" rid="fig6sdata1">Figure 6—source data 1</xref> shows that there is little difference in the peak heights at the metal ion positions in anomalous difference maps irrespective of wavelength, which strongly suggests that the metal site is occupied by Ca<sup>2+</sup> from the crystallization medium. Furthermore, the peaks were only about twice the height of those from well-ordered sulfur atoms in the structure. At these wavelengths, S has an anomalous f’ component of about 0.5 electrons. For Mn or Fe one would expect an anomalous signal around eight times that of S (<xref ref-type="supplementary-material" rid="fig6sdata2">Figure 6—source data 2</xref>). The presence of Ca<sup>2+</sup> is also consistent with the long coordination distances. Furthermore, an X-ray fluorescence spectrum of the crystal (not shown) revealed only traces of Mn or Fe.</p><p>Interestingly, Tyr207 is found near the metal site at the position expected for a radical-carrying Tyr, but it is not hydrogen-bonded to the metal site, its hydroxyl group being at around 6 Å from the side chain of Glu170. Tyr207 is H-bonded to the side chain of Thr294, but the latter is not H-bonded to a metal center ligand. On the other side of the metal site, Trp177 is H-bonded to the side chain of Glu263. This tryptophan is completely conserved in the NrdBi subclass (<xref ref-type="fig" rid="fig6s2">Figure 6—figure supplement 2</xref>). It makes the same interaction as Trp111 from <italic>E. coli</italic> NrdB, despite the fact that it is projected from the first helix of the 4-helix bundle containing the metal center ligands, rather than the second helix. The first helix of the bundle has a very unusual distortion in the middle (<xref ref-type="fig" rid="fig6s3">Figure 6—figure supplement 3</xref>). Normally this is an undistorted α-helix, but in <italic>L. blandensis</italic> NrdB, residues 171–175 form a loop that bulges away from the metal site, with the exception of Lys174, whose side chain is projected towards the metal site and is H-bonded to Glu170 (<xref ref-type="fig" rid="fig6">Figure 6e</xref>). The significance of this distortion is at present not clear. However we are certain that the distortion is not caused by the coordination of Ca<sup>2+</sup> instead of the native metal, as the structure is the same in crystals of the N-terminally truncated form grown in the presence of Mn<sup>2+</sup>, which will be presented elsewhere.</p><p>The nature of the native metallo-cofactor was addressed by X-band EPR spectroscopy and catalytically active samples were analyzed at 5–32 K. The spectra revealed a mixture of signals from low and high-valent manganese species (<xref ref-type="fig" rid="fig7">Figure 7a</xref>). In particular, at 5 K a 6-line signal attributable to low valent Mn (Mn<sup>II</sup>) was clearly visible, overlaid with a complex multiline signal with a width of approximately 1250G. Increasing the temperature to 32 K resulted in a significant decrease of the latter signal, while the 6-line feature remained relatively intense (<xref ref-type="fig" rid="fig7">Figure 7a</xref>, top and middle). The shape, width and temperature dependence of the multiline signal are all highly reminiscent of the signal reported for super-oxidized manganese catalase as well as the 16-line signal observed during the assembly of the dimanganese/tyrosyl radical cofactor in NrdF RNR, and are attributable to a strongly coupled Mn<sup>III</sup>Mn<sup>IV</sup> dimer (S<sub>Total</sub> = ½) (<xref ref-type="fig" rid="fig7">Figure 7a</xref>, bottom) (<xref ref-type="bibr" rid="bib15">Cotruvo et al., 2013</xref>; <xref ref-type="bibr" rid="bib73">Zheng et al., 1994</xref>). The low valent species appeared to be weakly bound to the protein, while the Mn<sup>III</sup>Mn<sup>IV</sup> dimer was retained in the protein following desalting (<xref ref-type="fig" rid="fig7s1">Figure 7—figure supplement 1</xref>). The observation of a high-valent Mn cofactor is consistent with the Mn-dependent increase in catalytic activity of the enzyme and its inhibition by the addition of Fe<sup>2+</sup>(<xref ref-type="fig" rid="fig7">Figure 7b–c</xref>), and is suggestive of a novel high-valent homodimeric Mn-cofactor. Indeed, earlier calculations have shown that high-valent Mn-dimers have reduction potentials similar to that of the tyrosyl radical in standard class I RNRs, but are hitherto not observed in RNRs (<xref ref-type="bibr" rid="bib59">Roos and Siegbahn, 2011</xref>). A more detailed biophysical characterization of this cofactor is currently ongoing.</p><fig-group><fig id="fig7" position="float"><object-id pub-id-type="doi">10.7554/eLife.31529.017</object-id><label>Figure 7.</label><caption><title>Type of dinuclear metal center of <italic>L. blandensis</italic> NrdB and metal-dependency of enzyme activity.</title><p>(<bold>a</bold>) X-band EPR spectra of catalytically active, non-reconstituted, samples recorded at 5 K (<italic>black</italic>, top); 32 K (<italic>red</italic>, middle) (signal intensity multiplied by 3.7 for clarity; multiline spectrum obtained by subtraction of a scaled 32K spectrum from the 5K spectrum (<italic>blue</italic>, bottom) (signal intensity multiplied by three for clarity). Instrument settings: microwave frequency = 9.28 GHz; power = 1 mW; modulation amplitude = 10G; modulation frequency = 100 kHz. (<bold>b</bold>) Enzyme activity of NrdB∆99 purified from heterologously expressed cultures grown with addition of different divalent metal ions as indicated; the Mn-sample was used for the EPR analysis. (<bold>c</bold>) Enzyme activity was measured after addition of a total concentration of 20 µM divalent metal ions to 10 µM of wild-type or NrdB∆99 protein as indicated. Enzyme activity without addition of metals was set as 100% and corresponded to 592 and 217 nmol mg<sup>−1</sup> min<sup>−1</sup> for wild type and NrdB∆99 enzymes respectively. Error bars indicate the standard deviation of three measurements.</p></caption><graphic mime-subtype="x-tiff" mimetype="image" xlink:href="elife-31529-fig7-v1"/></fig><fig id="fig7s1" position="float" specific-use="child-fig"><object-id pub-id-type="doi">10.7554/eLife.31529.018</object-id><label>Figure 7—figure supplement 1.</label><caption><title>X-band EPR spectra recorded at 5 K and 32 K of catalytically active samples before and after desalting treatment.</title><p>Following the desalting column the central 6-line feature is greatly diminished while the multiline signal appears unaffected. Thus, the high-valent Mn-dimer appears tightly bound to the protein and stable on the time-scale of the experiments (hours). As-isolated samples recorded at 5 K (black) and 33 K (dark blue, signal multiplied by 3.5 for clarity); desalted samples recorded at 5 K (grey) and 32 K (light blue, signal multiplied by four for clarity). Instrument settings: microwave frequency = 9.28 GHz; power = 1 mW; modulation amplitude = 10G; modulation frequency = 100 kHz.</p></caption><graphic mime-subtype="x-tiff" mimetype="image" xlink:href="elife-31529-fig7-figsupp1-v1"/></fig></fig-group></sec><sec id="s2-6"><title><italic>L. blandensis</italic> NrdB binds two nucleotide molecules per ATP-cone</title><p>The finding that two dATP molecules were bound to the ATP-cone in the 3D structure prompted us to investigate nucleotide binding using isothermal titration calorimetry (ITC). Binding curves for dATP, ATP and dADP to NrdB, including a reverse titration of NrdB to dATP, were all consistent with a single set of binding sites except for the ATP-cone deletion mutant (NrdBΔ99), which did not bind nucleotides at all (<xref ref-type="fig" rid="fig8">Figure 8</xref>). In all other titrations the fitted apparent N value was significantly above one, but to be meaningful the N value needs to be an integer. Using information available from the 3D structure, a fixed stoichiometry of 2 was used to fit dATP binding to NrdB. The fit indicated 59% active (i.e. nucleotide binding) protein. A fixed stoichiometry of 1 would result in higher than 100% active protein concentration, which is impossible. Fitting dADP and ATP with a 59% proportion of active protein taken from the dATP experiment, we could calculate stoichiometries of 2.2 and 2.1 for ATP and dADP respectively, indicating that each NrdB monomer can bind two molecules of adenosine nucleotides (<xref ref-type="fig" rid="fig8">Figure 8f</xref>). <italic>K<sub>d</sub></italic> for the three different nucleotides (<xref ref-type="fig" rid="fig8">Figure 8f</xref>) indicated a 38-fold and 15-fold lower affinity for ATP and dADP compared to dATP. Thermodynamic parameters (<xref ref-type="fig" rid="fig8">Figure 8f</xref>) indicated that the interactions are enthalpy-driven, with negative ΔH values of −79,–44 and −103 for dATP, ATP and dADP respectively.</p><fig id="fig8" position="float"><object-id pub-id-type="doi">10.7554/eLife.31529.019</object-id><label>Figure 8.</label><caption><title>Representative ITC thermograms obtained by titration of dATP (<bold>a</bold>), ATP (<bold>c</bold>) and dADP (<bold>d</bold>) into NrdB.</title><p>Isothermal calorimetric enthalpy changes (upper panel) and resulting binding isotherms (lower panel) are shown. Reverse titration of NrdB to dATP (<bold>b</bold>). Titration of dATP to NrdB∆99 (<bold>e</bold>). Thermodynamic parameters of ligand binding to NrdB (<bold>f</bold>). Binding isotherms were fitted using a one-set-of sites binding model. Values are reported as the mean ±SD of three titrations (and additional two reverse titrations for dATP). All titrations were performed at 10°C as described in Materials and methods. *=binding stoichiometry was kept constant N = 2, considering monomeric protein concentrations. ND = not detected.</p></caption><graphic mime-subtype="x-tiff" mimetype="image" xlink:href="elife-31529-fig8-v1"/></fig></sec></sec><sec id="s3" sec-type="discussion"><title>Discussion</title><p>Although allosteric regulation is built into many enzymes (<xref ref-type="bibr" rid="bib31">Gunasekaran et al., 2004</xref>), it can evolve in a surprisingly dynamic way (<xref ref-type="bibr" rid="bib5">Aravind and Koonin, 1999</xref>; <xref ref-type="bibr" rid="bib42">Lang et al., 2014</xref>; <xref ref-type="bibr" rid="bib44">Lundin et al., 2015</xref>). This has also been shown experimentally by grafting an allosteric domain to an enzyme that was previously not allosterically regulated (<xref ref-type="bibr" rid="bib19">Cross et al., 2013</xref>). The presence of an ATP-cone in the radical-generating subunit of <italic>L. blandensis</italic> RNR, provides, to our knowledge, the first example of another degree of evolutionary dynamics by the transfer of a domain conferring allosteric regulation to a non-homologous component of an enzyme complex.</p><p>It is critically important for an organism to control the supply of dNTPs to allow fidelity in DNA replication and repair (<xref ref-type="bibr" rid="bib45">Mathews, 2006</xref>). Specificity regulation of RNR makes sure relative concentrations of dNTPs fit the organism’s DNA composition. On the other hand, activity regulation assures that absolute concentrations of dNTPs follow the different requirements through the cell cycle (<xref ref-type="bibr" rid="bib32">Hofer et al., 2012</xref>). Specificity regulation of RNRs is ubiquitous, integrated in the catalytic subunit of the enzyme, and works via the classical homooligomeric model of allosteric regulation (<xref ref-type="bibr" rid="bib2">Andersson et al., 2000</xref>; <xref ref-type="bibr" rid="bib32">Hofer et al., 2012</xref>; <xref ref-type="bibr" rid="bib43">Larsson et al., 2004</xref>; <xref ref-type="bibr" rid="bib55">Reichard, 2010</xref>; <xref ref-type="bibr" rid="bib61">Swain and Gierasch, 2006</xref>; <xref ref-type="bibr" rid="bib64">Torrents et al., 2000</xref>; <xref ref-type="bibr" rid="bib74">Zimanyi et al., 2016</xref>). In contrast, the activity regulation is controlled by an accessory domain, the ATP-cone, and works by affecting the distribution of the holoenzyme heteromeric complexes. Moreover, the ATP-cone is only found in some RNRs, and appears to be gained by domain shuffling when evolutionary selection favours it and lost when selection decreases (<xref ref-type="bibr" rid="bib44">Lundin et al., 2015</xref>). These dynamics are further evidenced by the differences in mechanisms recently discovered in class I RNRs (<xref ref-type="bibr" rid="bib3">Ando et al., 2011</xref>, <xref ref-type="bibr" rid="bib4">2016</xref>; <xref ref-type="bibr" rid="bib26">Fairman et al., 2011</xref>; <xref ref-type="bibr" rid="bib35">Johansson et al., 2016</xref>; <xref ref-type="bibr" rid="bib36">Jonna et al., 2015</xref>). The current study was prompted by the interesting observation that several radical-generating subunits of the NrdBi subclass possess an N-terminal ATP-cone and that a few radical-generating subunits of the NrdF subclass possess a C-terminal ATP-cone. Our discovery evokes several pertinent questions: does the ATP-cone fused to a radical-generating subunit function as an allosteric on/off switch; how does it affect the distribution of holoenzyme complexes under active and inhibited conditions; is its structural mode of action similar to that of ATP-cones fused to the catalytic subunit?</p><p>We have delineated the function of the ATP-cone that is N-terminally fused to the <italic>L. blandensis</italic> NrdBi protein. In the presence of the positive effector ATP, <italic>L. blandensis</italic> NrdBi was a dimer, which by interaction with the <italic>L. blandensis</italic> catalytic subunit NrdAi formed the common active α<sub>2</sub>β<sub>2</sub> complex, also found in e.g. <italic>E. coli</italic>, <italic>P. aeruginosa</italic> and eukaryotic class I RNRs. Binding of dATP to the ATP-cone instead promoted oligomerization of <italic>L. blandensis</italic> NrdBi to an inactive β<sub>4</sub> complex, with a novel tetrameric structure revealed by crystallography. This oligomerization is reminiscent of the ‘ring-shaped’ α<sub>4</sub> and α<sub>6</sub> complexes formed by dATP binding to the NrdA-linked ATP-cones in <italic>P. aeruginosa</italic> and eukaryotic RNRs. When <italic>L. blandensis</italic> NrdAi was added to the dATP-loaded NrdBi tetramer, higher molecular mass complexes of α<sub>2</sub>β<sub>4</sub> and α<sub>4</sub>β<sub>4</sub> appeared. The NrdA dimers seem to bind to the NrdB tetramers in a ‘nonproductive’ orientation, and in other studied RNRs it usually means that the structure of the complexes does not allow efficient electron transfer between NrdA and NrdB. The crystal structure shows that the tetramerization of <italic>L. blandensis</italic> NrdBi leaves the putative interaction surface for NrdAi free, which is consistent with the possibility to form both α<sub>2</sub>β<sub>4</sub> and α<sub>4</sub>β<sub>4</sub> oligomers. However the structure does not suggest the structural basis for a disruption of the cysteinyl radical generation pathway in these non-productive complexes.</p><p>The structure of the dATP-loaded <italic>L. blandensis</italic> NrdB shows that it binds two dATP molecules per ATP-cone. Both molecules bind to the same site and interact with each other through a Mg<sup>2+</sup> ion. Most allosterically regulated RNRs characterized so far bind only one dATP molecule per ATP-cone. However, a novel class of ATP-cones that binds two dATP molecules was recently characterized in <italic>P. aeruginosa</italic> NrdA (<xref ref-type="bibr" rid="bib35">Johansson et al., 2016</xref>; <xref ref-type="bibr" rid="bib36">Jonna et al., 2015</xref>). The NrdB-linked ATP-cone of <italic>L. blandensis</italic> has sequence motifs characteristic of this kind of ATP-cone. The structure confirms that both dATP molecules bind essentially identically as in <italic>P. aeruginosa</italic> NrdA and that the ATP-cones make similar interactions to each other, distinct from those made in the eukaryotic α<sub>6</sub> complexes. It has also been shown in the RNR transcriptional regulator NrdR, that ATP and dATP bind with positive cooperativity to its ATP-cone (<xref ref-type="bibr" rid="bib48">McKethan and Spiro, 2013</xref>), implying binding of more than one nucleotide molecule.</p><p>The ATP-cone in <italic>L. blandensis</italic> NrdBi offers a unique possibility to measure its binding capacity for (deoxy)adenosine nucleotides. This has not been possible in earlier studied RNRs, where the ATP-cone is bound to the α subunit that also possesses a binding site for allosteric regulation of substrate specificity. ITC ligand binding studies confirmed that the <italic>L. blandensis</italic> ATP-cone bound two dATP molecules, and showed that it also can bind two molecules of ATP or two molecules of dADP. Structurally, binding of dADP is not surprising, since the γ-phosphates of the dATP molecules make only one interaction with the protein, through Arg102, and they only contribute 2 of the 6 coordinating atoms of the intervening Mg<sup>2+</sup> ion. Nonetheless, this is the first observation of dADP binding to the ATP-cone of an RNR enzyme. dADP inhibits enzyme activity in a similar manner to dATP, but higher concentrations are required. In vivo, deoxyribonucleoside diphosphates are rapidly converted to triphosphates and cellular dADP concentrations are very low (<xref ref-type="bibr" rid="bib46">Mathews, 2014</xref>; <xref ref-type="bibr" rid="bib67">Traut, 1994</xref>). Nevertheless, dADP is one of the products of <italic>L. blandensis</italic> RNR, and perhaps local concentrations are higher. The ability of dADP to regulate the activity of <italic>L. blandensis</italic> RNR may enable it to react more rapidly to changes in (deoxy)adenosine nucleotide concentrations and provide the cell with a fitness advantage. It can therefore not be excluded that dADP has a physiological role, although we think that the 15 times stronger affinity for dATP suggests that it is the major inhibitory nucleotide effector. Binding of deoxyadenosine di- and monophosphates has been described for the ATP-cone in NrdR (<xref ref-type="bibr" rid="bib30">Grinberg et al., 2006</xref>; <xref ref-type="bibr" rid="bib48">McKethan and Spiro, 2013</xref>).</p><p>Based on the variable occurrence of the ATP-cone in RNR catalytic subunits, we have earlier hypothesized that its presence in RNRs is part of a dynamic process of gains and losses on a relatively short evolutionary time scale (<xref ref-type="bibr" rid="bib44">Lundin et al., 2015</xref>). This suggests that the ATP-cone, contrary to what might be expected for a domain involved in allostery, does not require a long evolutionary period of integration with a protein to contribute to regulation and that it hence lends itself to a highly dynamic evolution of allosteric activity control (<xref ref-type="bibr" rid="bib44">Lundin et al., 2015</xref>). This hypothesis is nicely supported by the N-terminally positioned ATP-cone, in the radical-generating subunit, NrdB, of <italic>L. blandensis</italic> RNR described here. No RNR in the phylogenetic subclass NrdAi/Bi contains an ATP-cone in the catalytic subunit, and only a minority – mostly encoded by Flavobacteriia, a marine class of Bacteroidetes – have an NrdB with an ATP-cone, suggesting the relatively recent acquisition of the ATP-cone to an RNR subclass that is otherwise not activity regulated (<xref ref-type="fig" rid="fig1">Figure 1</xref>). Moreover, in the Ib subclass, which also lacks ATP-cones in the catalytic subunit, we detected a C-terminally positioned ATP-cone in the radical-generating subunit. This was found in only two sequences from closely related organisms and might hence be an example of an even more recent evolutionary event.</p><p>The evidence we have presented here for an ATP/dATP-sensing master switch of the <italic>L. blandensis</italic> NrdAi/NrdBi class I RNR, suggests a potential for the use of ATP-cones to control the activity of engineered proteins. Multimeric enzymes could be inactivated through sequestration of one member of an active complex, by control of dATP concentrations in the reaction mixture.</p><p>The surprises did not end with the discovery of a functional master switch in the <italic>L. blandensis</italic> NrdAi/NrdBi RNR. The active center of the radical generating subunit of class I RNRs have earlier been found to consist either of an Fe<sup>III</sup>Fe<sup>III</sup> or Mn<sup>III</sup>Mn<sup>III</sup> pair coupled to a tyrosine residue acting as long-term storage for the catalytically essential radical (<xref ref-type="bibr" rid="bib21">Berggren et al., 2017</xref>; <xref ref-type="bibr" rid="bib16">Cotruvo and Stubbe, 2012</xref>), or a Fe<sup>III</sup>Mn<sup>IV</sup> center not coupled to an amino acid radical (<xref ref-type="bibr" rid="bib29">Griese et al., 2014</xref>). Although further analyses are required to fully characterize the <italic>L. blandensis</italic> NrdBi active center, it appears to present a fourth type, a high-valent Mn<sup>III</sup>Mn<sup>IV</sup> center that lacks a suitably positioned radical storage amino acid. The evolutionary flexibility displayed by the ATP-cone appears hence all but equaled by the evolutionary tuning possibilities of the metal centers in the radical generating subunit of class I RNR.</p></sec><sec id="s4" sec-type="materials|methods"><title>Materials and methods</title><table-wrap id="keyresource" position="anchor"><label>Key resources table</label><table frame="hsides" rules="groups"><thead><tr><th>Reagent type (species) <break/>or resource</th><th>Designation</th><th>Source or reference</th><th>Identifiers</th></tr></thead><tbody><tr><td>Gene (<italic>Leeuwenhoekiella blandensis</italic> sp. nov. MED 217)</td><td>NrdAi</td><td>NA</td><td>WP_009781766</td></tr><tr><td>Gene (<italic>Leeuwenhoekiella blandensis</italic> sp. nov. MED 217)</td><td>NrdBi</td><td>NA</td><td>EAQ51288</td></tr><tr><td>Strain, strain background (<italic>Leeuwenhoekiella blandensis</italic>)</td><td valign="bottom"><italic>Leeuwenhoekiella blandensis sp. nov.</italic> MED 217</td><td>doi: 10.1099/ijs.0.64232–0</td><td/></tr><tr><td>Strain, strain background (<italic>Escherichia coli</italic>)</td><td><italic>Escherichia coli</italic> BL21(DE3)</td><td>(Novagen) Merck</td><td/></tr><tr><td>Strain, strain background (<italic>Escherichia coli</italic>)</td><td><italic>Escherichia coli</italic> DH5α</td><td>ThermoFisher Scientific</td><td/></tr><tr><td>Recombinant DNA reagent</td><td>pET-28a(+) vector (Novagen)</td><td>Merck</td><td/></tr><tr><td>Software, algorithm</td><td>HMMER</td><td valign="bottom">doi:10.1371/journal.pcbi.1002195</td><td>RRID:<ext-link ext-link-type="uri" xlink:href="https://scicrunch.org/resolver/SCR_005305">SCR_005305</ext-link></td></tr><tr><td>Software, algorithm</td><td>RefSeq</td><td/><td>RRID:<ext-link ext-link-type="uri" xlink:href="https://scicrunch.org/resolver/SCR_003496">SCR_003496</ext-link></td></tr><tr><td>Software, algorithm</td><td>ProbCons</td><td valign="bottom">doi:10.1101/gr.2821705</td><td>RRID:<ext-link ext-link-type="uri" xlink:href="https://scicrunch.org/resolver/SCR_011813">SCR_011813</ext-link></td></tr><tr><td>Software, algorithm</td><td>FastTree</td><td valign="bottom">doi:10.1371/journal.pone.0009490</td><td>RRID:<ext-link ext-link-type="uri" xlink:href="https://scicrunch.org/resolver/SCR_015501">SCR_015501</ext-link></td></tr><tr><td>Software, algorithm</td><td>XDS</td><td valign="bottom">doi:10.1107/s0907444909047337</td><td>RRID:<ext-link ext-link-type="uri" xlink:href="https://scicrunch.org/resolver/SCR_015652">SCR_015652</ext-link></td></tr><tr><td>Software, algorithm</td><td>CCP4</td><td valign="bottom">doi:10.1107/s0907444910045749</td><td>RRID:<ext-link ext-link-type="uri" xlink:href="https://scicrunch.org/resolver/SCR_007255">SCR_007255</ext-link></td></tr><tr><td>Software, algorithm</td><td>Phaser</td><td valign="bottom">doi:10.1107/s0021889807021206</td><td>RRID:<ext-link ext-link-type="uri" xlink:href="https://scicrunch.org/resolver/SCR_014219">SCR_014219</ext-link></td></tr><tr><td>Software, algorithm</td><td>PDB</td><td/><td>RRID:<ext-link ext-link-type="uri" xlink:href="https://scicrunch.org/resolver/SCR_012820">SCR_012820</ext-link></td></tr><tr><td>Software, algorithm</td><td>Coot</td><td valign="bottom">doi:10.1107/s0907444910007493</td><td>RRID:<ext-link ext-link-type="uri" xlink:href="https://scicrunch.org/resolver/SCR_014222">SCR_014222</ext-link></td></tr><tr><td>Software, algorithm</td><td>Buccaneer</td><td valign="bottom">doi:10.1107/s0907444906022116</td><td>RRID:<ext-link ext-link-type="uri" xlink:href="https://scicrunch.org/resolver/SCR_014221">SCR_014221</ext-link></td></tr><tr><td>Software, algorithm</td><td>Refmac</td><td valign="bottom">doi:10.1107/s0907444996012255</td><td>RRID:<ext-link ext-link-type="uri" xlink:href="https://scicrunch.org/resolver/SCR_014225">SCR_014225</ext-link></td></tr><tr><td>Software, algorithm</td><td>Buster</td><td/><td>RRID:<ext-link ext-link-type="uri" xlink:href="https://scicrunch.org/resolver/SCR_015653">SCR_015653</ext-link></td></tr><tr><td>Software, algorithm</td><td>MolProbity</td><td valign="bottom">doi:10.1107/s0907444909042073</td><td>RRID:<ext-link ext-link-type="uri" xlink:href="https://scicrunch.org/resolver/SCR_014226">SCR_014226</ext-link></td></tr></tbody></table></table-wrap><sec id="s4-1"><title>Cloning</title><p>DNA fragments encoding NrdAi (WP_009781766) and NrdBi (EAQ51288) were amplified by PCR from <italic>Leeuwenhoekiella blandensis</italic> sp. nov. strain MED217 genomic DNA, isolated as described previously (<xref ref-type="bibr" rid="bib53">Pinhassi et al., 2006</xref>), using specific primers: NrdA: LBR1_For 5'- cgagCATATGAGAGAAAACACTACCAAAC-3' and LBR1_Rev 5'- gcaaGGATCCTTAAGCTTCACAGCTTACA-3'. NrdB: LBR2_For 5'-cgagCATATGAGTTCACAAGAGATCAAA-3', LBR2_REV 5'- gcaaGGATCCTTAAAATAAGTCGTCGCTG-3', The PCR products were purified, cleaved with NdeI and BamHI restriction enzymes and inserted into a pET-28a(+) expression vector (Novagen, Madison, Wisconsin, USA). The obtained constructs pET-<italic>nrdA</italic> and pET-<italic>nrdB</italic> contained an N-terminal hexahistidine (His) tag and thrombin cleavage site. To construct a truncated NrdB mutant, lacking the entire ATP-cone domain, new forward primer LBR2∆99_For 5'-cgatCATATGCTGGAGCGTAAAACAAAT-3' was used with LBR2_REV to yield a pET-<italic>nrdB</italic>∆99. The cloning process and the resulting construct was similar to that of the wild type protein, except that it lacked sequence coding for the N-terminal 99 amino acids.</p></sec><sec id="s4-2"><title>Protein expression</title><p>Overnight cultures of <italic>E. coli</italic> BL21(DE3)/pET28a(+) bearing pET-<italic>nrdA</italic>, pET-<italic>nrdB</italic> and pET-<italic>nrdB</italic>∆99 were diluted to an absorbance at 600 nm of 0.1 in LB (Luria-Bertani) liquid medium, containing kanamycin (50 μg/ml) and shaken vigorously at 37°C. At an absorbance at 600 nm of 0.8, isopropyl-β-D-thiogalactopyranoside (Sigma) was added to a final concentration of 0.01 mM for NrdA expression and 0.5 mM for NrdB and NrdB∆99 expression. For particular experiments, 0.5 mM MnSO<sub>4</sub> or 0.5 mM FeNH<sub>4</sub>(SO4)<sub>2</sub> or the combination of both metals (0.4 mM and 0.25 mM respectively) were added to NrdB∆99 cultures. The cells were grown overnight at 14°C for NrdA expression and 20°C for NrdB and NrdB∆99 expression and harvested by centrifugation.</p></sec><sec id="s4-3"><title>Protein purification</title><p>The cell pellet was resuspended in lysis buffer: 50 mM Tris-HCl pH 7.6 containing 300 mM NaCl, 20% glycerol, 10 mM imidazole, 1 mM PMSF. Cells were disrupted by high pressure homogenization and the lysate was centrifuged at 18,000 × g for 45 min at 4°C. The recombinant His-tagged protein was first isolated by metal-chelate affinity chromatography using ÄKTA prime system (GE Healthcare): the supernatant was loaded on a HisTrap FF Ni Sepharose column (GE Healthcare), equilibrated with lysis buffer (w/o PMSF), washed thoroughly with buffer and eluted with buffer containing 500 mM imidazole. Further purification was accomplished by fast protein liquid chromatography (FPLC) on a 125 ml column packed with Superose 12 Prep Grade or HiLoad 16/600 Superdex 200 pg column (GE Healthcare) using ÄKTA prime system, equilibrated with buffer containing 50 mM Tris-HCl pH 7.6, 300 mM NaCl, 10–20% glycerol. Eluted protein was collected. In the case of NrdA, all purification steps were performed in the presence of 2 mM DTT. Protein concentration was determined by measuring the UV absorbance at 280 nm based on protein theoretical extinction coefficients 91,135, 46,870 and 39,420 M<sup>−1</sup> cm<sup>−1</sup> for NrdA, NrdB and NrdB∆99 respectively. Proteins were concentrated using Amicon Ultra-15 centrifugal filter units (Millipore), frozen in liquid nitrogen and stored at −80°C until used.</p><p>For crystallization, NrdB was subsequently cleaved by thrombin (Novagen) to remove the hexahistidine tag. 41 mg NrdB was incubated with 25 U thrombin at 6°C for 3 hr, in a buffer containing 40 mM Tris-HCl pH 8.4, 150 mM NaCl, and 2.5 mM CaCl<sub>2</sub> in a total volume of 50 ml. Subsequently, imidazole to a final concentration of 20 mM was added and the reaction mixture was applied to a HisTrap FF Ni Sepharose column in a buffer containing 20 mM imidazole. Unbound protein was collected, concentrated and further purified by FPLC (see above) in a buffer containing Tris-HCl pH 7.6, 300 mM NaCl, and 10% glycerol. The thrombin-cleaved NrdB contained three additional residues (GlySerHis) that originated from the cleavage site of the enzyme at its N-terminus. Protein purity was evaluated by SDS–PAGE (12%) stained with Coomassie Brilliant Blue.</p><p>For EPR measurements, NrdB∆99 was frozen in liquid nitrogen in EPR tubes directly after imidazole elution from the HisTrap column. Additional EPR samples were frozen after desalting the protein using PD-10 desalting columns (GE Healthcare).</p></sec><sec id="s4-4"><title>Enzyme activity assays</title><p>Enzyme assays were performed at room temperature in 50 mM Tris-HCl at pH 8 in volumes of 50 μl. Reaction conditions, giving maximal activity were determined experimentally. In a standard reaction the constituents were; 10 mM DTT, 10 mM MgAc, 10 mM KCl, 0.8 mM (or when indicated 3 mM) CDP, and various concentrations of allosteric effectors ATP, dATP or dADP. Mixtures of 0.5 μM NrdA and 2 μM wild type NrdB or NrdB∆99 (for determination of s-site K<sub>L</sub>) (<xref ref-type="fig" rid="fig3">Figure 3a–b</xref>) or 0.5 μM of NrdB and 2 uM NrdA (for determination of a-site K<sub>L</sub>), (<xref ref-type="fig" rid="fig3">Figure 3c–f</xref>) were used. Some components were explicitly varied in specific experiments. Generally, 0.8 mM CDP was used as substrate. High CDP concentration (3 mM) was used for dADP titrations, to exclude potential product inhibition by binding of dADP to the active site. When dTTP was used as an s-site effector, 0.5 mM or 0.8 mM GDP was used as substrate. In four substrate assays, the four substrates CDP, ADP, GDP and UDP were simultaneously present in the mixture at concentrations of 0.5 mM each. The substrate mixture was added last to start the reactions. Certain assays were performed in the presence of Mn(CH<sub>3</sub>COO)<sub>2</sub> or FeNH<sub>4</sub>(SO4): 20 μM of the indicated metal was added to 10 μM NrdB or NrdB∆99 protein, incubated for 10 min, mixed with NrdA and added to the reaction mixture.</p><p>Enzyme reactions were incubated for 10–30 min and then stopped by the addition of methanol. The chosen incubation time gave a maximum substrate turnover of 30%. Substrate conversion was analyzed by HPLC using a Waters Symmetry C18 column (150 × 4.6 mm, 3.5 μm pore size) equilibrated with buffer A. 25 μl samples were injected and eluted at 1 ml/min with a linear gradient of 0–100% buffer B (buffer A: 10% methanol in 50 mM potassium phosphate buffer, pH 7.0, supplemented with 10 mM tributylammonium hydroxide; buffer B: 30% methanol in 50 mM potassium phosphate buffer, pH 7.0, supplemented with 10 mM tributylammonium hydroxide). Compound identification was achieved by comparison with injected standards. Relative quantification was obtained by peak height measurements in the chromatogram (UV absorbance at 271 nm) in relation to standards. Specific activities of either NrdA (<xref ref-type="fig" rid="fig2">Figure 2a–b</xref>) or NrdB (<xref ref-type="fig" rid="fig2">Figure 2c–f</xref>) were determined. Specific activities varied between protein preparations. In some cases the data was standardized to activity percent, where 100% was determined as maximum enzyme activity in a specific condition.</p><p>From a direct plot of activity versus concentration of effector, the K<sub>L</sub> values for binding of effectors to the s-site and the a-site, were calculated in SigmaPlot using the equation:<disp-formula id="equ1"><mml:math id="m1"><mml:mstyle displaystyle="true" scriptlevel="0"><mml:mrow><mml:mi mathvariant="normal">V</mml:mi><mml:mo>=</mml:mo><mml:msub><mml:mi mathvariant="normal">V</mml:mi><mml:mrow><mml:mi mathvariant="normal">m</mml:mi><mml:mi mathvariant="normal">a</mml:mi><mml:mi mathvariant="normal">x</mml:mi></mml:mrow></mml:msub><mml:mo>×</mml:mo><mml:mo stretchy="false">[</mml:mo><mml:mi mathvariant="normal">d</mml:mi><mml:mi mathvariant="normal">N</mml:mi><mml:mi mathvariant="normal">T</mml:mi><mml:mi mathvariant="normal">P</mml:mi><mml:mo stretchy="false">]</mml:mo><mml:mrow><mml:mo>/</mml:mo></mml:mrow><mml:mo stretchy="false">(</mml:mo><mml:msub><mml:mi mathvariant="normal">K</mml:mi><mml:mi mathvariant="normal">L</mml:mi></mml:msub><mml:mo>+</mml:mo><mml:mo stretchy="false">[</mml:mo><mml:mi mathvariant="normal">d</mml:mi><mml:mi mathvariant="normal">N</mml:mi><mml:mi mathvariant="normal">T</mml:mi><mml:mi mathvariant="normal">P</mml:mi><mml:mo stretchy="false">]</mml:mo><mml:mo stretchy="false">)</mml:mo></mml:mrow></mml:mstyle></mml:math></disp-formula>and K<sub>i</sub> for non-competitive dATP inhibition at NrdB was calculated in Sigmaplot using the equation:<disp-formula id="equ2"><mml:math id="m2"><mml:mstyle displaystyle="true" scriptlevel="0"><mml:mrow><mml:mi mathvariant="normal">V</mml:mi><mml:mo>=</mml:mo><mml:msub><mml:mi mathvariant="normal">V</mml:mi><mml:mrow><mml:mi mathvariant="normal">m</mml:mi><mml:mi mathvariant="normal">a</mml:mi><mml:mi mathvariant="normal">x</mml:mi></mml:mrow></mml:msub><mml:mrow><mml:mo>/</mml:mo></mml:mrow><mml:mo stretchy="false">(</mml:mo><mml:mn>1</mml:mn><mml:mo>+</mml:mo><mml:mo stretchy="false">[</mml:mo><mml:mi mathvariant="normal">d</mml:mi><mml:mi mathvariant="normal">N</mml:mi><mml:mi mathvariant="normal">T</mml:mi><mml:mi mathvariant="normal">P</mml:mi><mml:mo stretchy="false">]</mml:mo><mml:mrow><mml:mo>/</mml:mo></mml:mrow><mml:msub><mml:mi mathvariant="normal">K</mml:mi><mml:mi mathvariant="normal">i</mml:mi></mml:msub><mml:mo stretchy="false">)</mml:mo></mml:mrow></mml:mstyle></mml:math></disp-formula></p></sec><sec id="s4-5"><title>GEMMA analysis</title><p>In GEMMA, biomolecules are electrosprayed into gas phase, neutralized to singly charged particles, and the gas phase electrophoretic mobility is measured with a differential mobility analyzer. The mobility of an analyzed particle is proportional to its diameter, which therefore allows for quantitative analysis of the different particle sizes contained in a sample (<xref ref-type="bibr" rid="bib40">Kaufman et al., 1996</xref>). The GEMMA instrumental setup and general procedures were as described previously (<xref ref-type="bibr" rid="bib56">Rofougaran et al., 2008</xref>). NrdA, NrdB and NrdB∆99 proteins were equilibrated by Sephadex G-25 chromatography into a buffer containing 100 mM ammonium acetate, pH 7.8. In addition, 2 mM DTT was added to the NrdA protein solutions to increase protein stability. Prior to GEMMA analysis, the protein samples were diluted to a concentration of 0.025–0.1 mg/ml in a buffer containing 20 mM ammonium acetate, pH 7.5, 0.005% (v/v) Tween 20, nucleotides (when indicated), and magnesium acetate (equimolar to the total nucleotide concentration), incubated for 5 min at room temperature, centrifuged and applied to the GEMMA instrument. Protein concentrations higher than normally recommended for GEMMA were needed to see the larger oligomeric complexes and the experiments to measure NrdA-NrdB interactions were run at as low flow rate as possible (driven by 1.4 Psi pressure) to minimize false interactions that may appear with elevated protein concentration if the flow-rate recommended by the manufacturer is used (3.7 Psi). Most of our experiments were performed with a flow rate driven by 2 Psi.</p></sec><sec id="s4-6"><title>Analytical size exclusion chromatography</title><p>Fast protein liquid chromatography on a Superdex 200 PC 3.2/30 column (with a total volume of 2.4 ml) and ÄKTA prime system (GE Healthcare) was performed. The column was equilibrated with SEC buffer containing 50 mM Tris-HCl pH 8, 50 mM KCl, 10% glycerol, 10 mM magnesium acetate, 2 mM DTT and when applicable either 3 mM ATP or 0.1–0.5 mM dATP. 50 µL samples containing NrdA, NrdB or both subunits in the presence or the absence of indicated amounts of nucleotides, were pre-incubated for 10 min in room temperature, centrifuged and applied to the column at a temperature of 7°C with a flow rate of 0.07 ml/min. When nucleotides were added to proteins, they were also included in the buffer at the same concentration to avoid dissociation of nucleotide-induced protein complexes during the run. Varying concentrations of proteins were used in the range of 10–113 µM and 5–150 µM for NrdA and NrdB respectively. For complex formation, 10–20 µM NrdA and 10–40 µM NrdB were used in ratios of 1:1 or 1:2. Representative SEC chromatograms in which 20 µM NrdA, 20 µM NrdB or a mixture of 25 µM and 50 µM NrdA and NrdB respectively are shown in <xref ref-type="fig" rid="fig5">Figure 5</xref>. Molecular weight was estimated based on a calibration curve, derived from globular protein standards using high molecular weight SEC marker kit (GE Healthcare). Standard deviations were calculated from at least 3 s experiments. The experiments in <xref ref-type="fig" rid="fig5s1">Figure 5—figure supplement 1</xref> were run in a similar way but using a Superdex 200 10/300 GL column (loop size 100 µl and flow rate 0.5 ml/min) with a SEC buffer containing 50 mM Tris-HCl pH 7.6, 150 mM KCl, and 10 mM magnesium chloride. Some experiments with ATP or dATP in the mobile phase were monitored at 290 nm to reduce the absorbance from the nucleotides.</p></sec><sec id="s4-7"><title>EPR measurements</title><p>Measurements were performed on a Bruker ELEXYS E500 spectrometer using an ER049X SuperX microwave bridge in a Bruker SHQ0601 cavity equipped with an Oxford Instruments continuous flow cryostat and using an ITC 503 temperature controller (Oxford Instruments, Oxford, United Kingdom). Measurement temperatures ranged from 5 to 32 K, using liquid helium as coolant. The spectrometer was controlled by the Xepr software package (Bruker).</p></sec><sec id="s4-8"><title>Bioinformatics</title><p>RNR protein sequences were collected and scored using HMMER (<xref ref-type="bibr" rid="bib22">Eddy, 2011</xref>) HMM profiles in the RNRdb (<ext-link ext-link-type="uri" xlink:href="http://rnrdb.pfitmap.org">http://rnrdb.pfitmap.org</ext-link>). ATP-cones were identified with HMMER and the Pfam ATP-cone HMM profile: PF03477 (<xref ref-type="bibr" rid="bib28">Finn et al., 2010</xref>). Sequences representing the diversity of NrdB were selected by clustering all NrdB sequences from RefSeq at an identity threshold of 70% using VSEARCH (<xref ref-type="bibr" rid="bib58">Rognes et al., 2016</xref>). Sequences were aligned with ProbCons (<xref ref-type="bibr" rid="bib20">Do et al., 2005</xref>) and reliable positions for phylogenetic reconstruction were manually selected. A maximum likelihood phylogeny was estimated with FastTree 2 (<xref ref-type="bibr" rid="bib54">Price et al., 2010</xref>).</p></sec><sec id="s4-9"><title>Isothermal titration calorimetry (ITC) measurements</title><p>Isothermal titration calorimetry (ITC) experiments were carried out on a MicroCal PEAQ-ITC system (Malvern Instruments Ltd) in a buffer containing 25 mM HEPES (pH 7.65), 150 mM NaCl, and 10% glycerol, 2 mM tris(2-carboxyethyl)phosphine, and 5 mM MgCl<sub>2</sub>. Measurements were done at 10°C. The initial injection volume was 0.4 μl over a duration of 0.8 s. All subsequent injection volumes were 2–2.5 μl over 4–5 s with a spacing of 150 s between the injections. Data for the initial injection were not considered. For dATP binding analysis, the concentration of NrdB in the cell was 12 µM and dATP in syringe 120 or 140 µM. Reverse titrations were performed with 113 µM NrdB in the syringe and 12 or 30 µM dATP in the cell. For titration of dATP into NrdB∆99, protein concentration in the cell and dATP concentration in the syringe were 50 µM and 900 µM respectively. For dADP binding analysis, the NrdB concentration in the cell was 20–50 µM and ligand concentrations in the syringe were 500–750 µM. For titration of ATP into NrdB, cell and syringe concentrations were 50 and 1600 µM respectively. The data were analyzed using the built-in one set of sites model of the MicroCal PEAQ-ITC Analysis Software (Malvern Instruments Ltd). A fixed ligand/protein stoichiometry of 2 was used for dATP to NrdB titrations. Standard deviations in thermodynamic parameters, N and <italic>K<sub>d</sub></italic> were estimated from the fits of three different titrations.</p></sec><sec id="s4-10"><title>Crystallization and data collection</title><p>The purified NrdB, digested by thrombin to remove the hexahistidine tag (see above), was used for crystallization. The protein at a concentration of 9.6 mg/ml was mixed with 20 mM MgCl<sub>2</sub>, 2 mM TCEP and 5 mM dATP, incubated for 30 min and used for setting up drops using commercially available screens. An initial crystal hit was obtained by the sitting drop vapor diffusion method with a protein to reservoir volume ratio of 200:200 nL and incubated with a 45 μl reservoir at 20 °C in a Triple Drop UV Polymer Plate (Molecular Dimensions, UK). A Mosquito nanoliter pipetting robot (TTP Labtech, UK) was used to set up drops, which were imaged by the Minstrel HT UV imaging system (Rigaku Corporation, USA) available at the Lund Protein Production Platform (LP3). Crystals were obtained with a reservoir containing 0.2 M CaCl<sub>2</sub>, 0.1 M Tris pH 8.0% and 20% w/v PEG 600 (condition #57 of the PACT screen). The crystals were then further optimized using an additive screen (Hampton Research, USA) and diffraction quality crystals were obtained within 1 week from a crystallization solution containing an additional 3% 6-aminohexanoic acid. Crystals were picked up directly from the drop without cryoprotectant and data were collected at 100 K using the ID23-1 beamline at the ESRF, Grenoble, France. The crystals are in space group P1 with unit cell dimensions a = 74.0, b = 90.5, c = 90.9, α = 110.8, β = 99.0, γ = 114.1, containing one NrdB tetramer in the unit cell. The solvent content is 49.5%.</p></sec><sec id="s4-11"><title>Structure determination and model building</title><p>The diffraction images were integrated using the program XDS (<xref ref-type="bibr" rid="bib38">Kabsch, 2010</xref>) and scaled using the program Aimless (<xref ref-type="bibr" rid="bib25">Evans and Murshudov, 2013</xref>) from the CCP4 package (<xref ref-type="bibr" rid="bib70">Winn et al., 2011</xref>). The structure was solved by molecular replacement (MR) in two steps, using Phaser (<xref ref-type="bibr" rid="bib47">McCoy et al., 2007</xref>). First the structure of NrdB∆99 was solved to 1.7 Å resolution using the most homologous structure in the PDB, that of NrdF from <italic>Chlamydia trachomatis</italic> (PDB: 1SYY) (<xref ref-type="bibr" rid="bib33">Högbom et al., 2004</xref>). This structure was rebuilt manually in Coot (<xref ref-type="bibr" rid="bib23">Emsley et al., 2010</xref>) and using Buccaneer (<xref ref-type="bibr" rid="bib17">Cowtan, 2006</xref>) then refined to convergence using Refmac5 (<xref ref-type="bibr" rid="bib49">Murshudov et al., 1997</xref>) and Buster (<xref ref-type="bibr" rid="bib11">Bricogne et al., 2016</xref>). Full details of this structure will be presented elsewhere. In the second step, a multi-body molecular replacement search was carried out using four copies of NrdB∆99 and four copies of the ATP-cone domain from <italic>P. aeruginosa</italic> NrdA (PDB: 5IM3) (<xref ref-type="bibr" rid="bib35">Johansson et al., 2016</xref>) prepared by side chain truncation using Chainsaw (<xref ref-type="bibr" rid="bib60">Stein, 2008</xref>). A single solution was found in which all 8 bodies were placed, with a translation function Z score (TFZ) of 12.2. After rearrangement of the ATP-cones from the MR solution to the N-termini of their respective core domains, the structure was refined using Refmac5. Some automatic building was performed using Buccaneer and manual rebuilding in Coot. Final refinement was done using Buster (<xref ref-type="bibr" rid="bib11">Bricogne et al., 2016</xref>). Automatically-generated non-crystallographic symmetry restraints were used. Geometry was validated using the MolProbity server (<xref ref-type="bibr" rid="bib14">Chen et al., 2010</xref>).</p></sec><sec id="s4-12"><title>Metal characterization using anomalous diffraction</title><p>To establish the nature of the metal ions in the crystal, an anomalous diffraction experiment was conducted at three wavelengths, one on the near-high-energy side of the Fe K edge (1.72 Å), where both Mn and Fe should have a strong anomalous signal, one near the Mn K edge (1.87 Å), where only Mn should have a strong signal, and one on the low energy side of the Mn edge (1.92 Å), where neither Mn nor Fe should have a strong signal but Ca<sup>2+</sup> will have a small residual signal (<xref ref-type="supplementary-material" rid="fig6sdata1">Figure 6—source data 1</xref>). These data were collected at EMBL station P14 of the PETRA-III synchrotron in Hamburg, Germany. The data at different wavelengths were collected in non-overlapping stripes on the crystal to avoid radiation damage that might affect the relative anomalous signals, which were found to be weak at all wavelengths. The structure was refined against all three datasets to a common resolution of 2.5 Å and the relative heights of peaks in the anomalous difference maps at were used to identify the metal. These are presented in <xref ref-type="supplementary-material" rid="fig6sdata2">Figure 6—source data 2</xref>. The refinement was done and anomalous difference maps calculated and analyzed using Buster (<xref ref-type="bibr" rid="bib11">Bricogne et al., 2016</xref>).</p></sec></sec></body><back><ack id="ack"><title>Acknowledgements</title><p>We want to thank Jarone Pinhassi and Sabina Arnautovic, Linneaus University, Kalmar, Sweden, for the kind gift of <italic>Leeuwenhoekiella blandensis</italic> DNA, Yuliya Leontyeva, Jan-Olov Persson and Rolf Sundberg, Department of Mathematics, Stockholm University, Sweden, for excellent statistical analysis of ligand binding, Eva Muñoz and Angel Piñeiro, AFFINImeter, Santiago de Compostela, Spain for valuable assistance with analysis of ITC titrations, Hanna Jankevics Jones and John Stenson, Malvern Instruments Ltd, Malvern, UK for highly appreciated help with protein biophysical characterization and Fredrik Tholander, Karolinska Institute, Stockholm, Sweden, for generously providing his HPLC instrument for the enzyme assays. We thank the crystallization facility at Lund Protein Production Platform for crystallization trials and staff at EMBL Hamburg and ESRF beamlines, in particular Gleb Bourenkov, for assistance with data collection. This study was supported by grants from the Swedish Cancer Society (CAN 2016/670 to BMS), the Swedish Research Council (2016–01920 to BMS, 2016–04855 to DTL), the Wenner-Gren Foundations (to BMS) and the Carl Trygger Foundation (to AH). Work in the laboratory of GB is supported by the Swedish Research Council (621–2014- 5670), the Swedish Research Council for Environment, Agricultural Sciences and Spatial Planning (213-2014-880) and the European Research Council (714102).</p></ack><sec id="s5" sec-type="additional-information"><title>Additional information</title><fn-group content-type="competing-interest"><title>Competing interests</title><fn fn-type="COI-statement" id="conf1"><p>No competing interests declared</p></fn></fn-group><fn-group content-type="author-contribution"><title>Author contributions</title><fn fn-type="con" id="con1"><p>Conceptualization, Data curation, Formal analysis, Investigation, Visualization, Methodology, Writing—original draft, Writing—review and editing</p></fn><fn fn-type="con" id="con2"><p>Conceptualization, Formal analysis, Investigation, Visualization, Methodology, Writing—original draft, Writing—review and editing</p></fn><fn fn-type="con" id="con3"><p>Formal analysis, Investigation, Methodology, Writing—review and editing</p></fn><fn fn-type="con" id="con4"><p>Formal analysis, Methodology</p></fn><fn fn-type="con" id="con5"><p>Methodology</p></fn><fn fn-type="con" id="con6"><p>Methodology</p></fn><fn fn-type="con" id="con7"><p>Methodology, Writing—review and editing</p></fn><fn fn-type="con" id="con8"><p>Data curation, Formal analysis, Funding acquisition</p></fn><fn fn-type="con" id="con9"><p>Conceptualization, Writing—review and editing</p></fn><fn fn-type="con" id="con10"><p>Investigation, Methodology, Writing—review and editing</p></fn><fn fn-type="con" id="con11"><p>Conceptualization, Data curation, Formal analysis, Funding acquisition, Investigation, Methodology, Writing—review and editing</p></fn><fn fn-type="con" id="con12"><p>Conceptualization, Data curation, Formal analysis, Funding acquisition, Visualization, Writing—original draft, Writing—review and editing</p></fn><fn fn-type="con" id="con13"><p>Conceptualization, Data curation, Formal analysis, Supervision, Funding acquisition, Writing—original draft, Project administration, Writing—review and editing</p></fn></fn-group></sec><sec id="s6" sec-type="supplementary-material"><title>Additional files</title><supplementary-material id="transrepform"><object-id pub-id-type="doi">10.7554/eLife.31529.020</object-id><label>Transparent reporting form</label><media mime-subtype="pdf" mimetype="application" xlink:href="elife-31529-transrepform-v1.pdf"/></supplementary-material></sec><ref-list><title>References</title><ref id="bib1"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ahmad</surname> <given-names>MF</given-names></name><name><surname>Dealwis</surname> <given-names>CG</given-names></name></person-group><year iso-8601-date="2013">2013</year><article-title>The structural basis for the allosteric regulation of ribonucleotide reductase</article-title><source>Progress in Molecular Biology and Translational Science</source><volume>117</volume><fpage>389</fpage><lpage>410</lpage><pub-id pub-id-type="doi">10.1016/B978-0-12-386931-9.00014-3</pub-id><pub-id pub-id-type="pmid">23663976</pub-id></element-citation></ref><ref id="bib2"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Andersson</surname> <given-names>J</given-names></name><name><surname>Westman</surname> <given-names>M</given-names></name><name><surname>Hofer</surname> <given-names>A</given-names></name><name><surname>Sjoberg</surname> <given-names>BM</given-names></name></person-group><year iso-8601-date="2000">2000</year><article-title>Allosteric regulation of the class III anaerobic ribonucleotide reductase from bacteriophage T4</article-title><source>Journal of Biological Chemistry</source><volume>275</volume><fpage>19443</fpage><lpage>19448</lpage><pub-id pub-id-type="doi">10.1074/jbc.M001490200</pub-id><pub-id pub-id-type="pmid">10748029</pub-id></element-citation></ref><ref id="bib3"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ando</surname> <given-names>N</given-names></name><name><surname>Brignole</surname> <given-names>EJ</given-names></name><name><surname>Zimanyi</surname> <given-names>CM</given-names></name><name><surname>Funk</surname> <given-names>MA</given-names></name><name><surname>Yokoyama</surname> <given-names>K</given-names></name><name><surname>Asturias</surname> <given-names>FJ</given-names></name><name><surname>Stubbe</surname> <given-names>J</given-names></name><name><surname>Drennan</surname> <given-names>CL</given-names></name></person-group><year iso-8601-date="2011">2011</year><article-title>Structural interconversions modulate activity of Escherichia coli ribonucleotide reductase</article-title><source>PNAS</source><volume>108</volume><fpage>21046</fpage><lpage>21051</lpage><pub-id pub-id-type="doi">10.1073/pnas.1112715108</pub-id><pub-id pub-id-type="pmid">22160671</pub-id></element-citation></ref><ref id="bib4"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ando</surname> <given-names>N</given-names></name><name><surname>Li</surname> <given-names>H</given-names></name><name><surname>Brignole</surname> <given-names>EJ</given-names></name><name><surname>Thompson</surname> <given-names>S</given-names></name><name><surname>McLaughlin</surname> <given-names>MI</given-names></name><name><surname>Page</surname> <given-names>JE</given-names></name><name><surname>Asturias</surname> <given-names>FJ</given-names></name><name><surname>Stubbe</surname> <given-names>J</given-names></name><name><surname>Drennan</surname> <given-names>CL</given-names></name></person-group><year iso-8601-date="2016">2016</year><article-title>Allosteric inhibition of human ribonucleotide reductase by datp entails the stabilization of a hexamer</article-title><source>Biochemistry</source><volume>55</volume><fpage>373</fpage><lpage>381</lpage><pub-id pub-id-type="doi">10.1021/acs.biochem.5b01207</pub-id><pub-id pub-id-type="pmid">26727048</pub-id></element-citation></ref><ref id="bib5"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Aravind</surname> <given-names>L</given-names></name><name><surname>Koonin</surname> <given-names>EV</given-names></name></person-group><year iso-8601-date="1999">1999</year><article-title>Gleaning non-trivial structural, functional and evolutionary information about proteins by iterative database searches</article-title><source>Journal of Molecular Biology</source><volume>287</volume><fpage>1023</fpage><lpage>1040</lpage><pub-id pub-id-type="doi">10.1006/jmbi.1999.2653</pub-id><pub-id pub-id-type="pmid">10222208</pub-id></element-citation></ref><ref id="bib6"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Aravind</surname> <given-names>L</given-names></name><name><surname>Wolf</surname> <given-names>YI</given-names></name><name><surname>Koonin</surname> <given-names>EV</given-names></name></person-group><year iso-8601-date="2000">2000</year><article-title>The ATP-cone: an evolutionarily mobile, ATP-binding regulatory domain</article-title><source>Journal of Molecular Microbiology and Biotechnology</source><volume>2</volume><fpage>191</fpage><lpage>194</lpage><pub-id pub-id-type="pmid">10939243</pub-id></element-citation></ref><ref id="bib7"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Aye</surname> <given-names>Y</given-names></name><name><surname>Brignole</surname> <given-names>EJ</given-names></name><name><surname>Long</surname> <given-names>MJ</given-names></name><name><surname>Chittuluru</surname> <given-names>J</given-names></name><name><surname>Drennan</surname> <given-names>CL</given-names></name><name><surname>Asturias</surname> <given-names>FJ</given-names></name><name><surname>Stubbe</surname> <given-names>J</given-names></name></person-group><year iso-8601-date="2012">2012</year><article-title>Clofarabine targets the large subunit (α) of human ribonucleotide reductase in live cells by assembly into persistent hexamers</article-title><source>Chemistry &amp; Biology</source><volume>19</volume><fpage>799</fpage><lpage>805</lpage><pub-id pub-id-type="doi">10.1016/j.chembiol.2012.05.015</pub-id><pub-id pub-id-type="pmid">22840768</pub-id></element-citation></ref><ref id="bib8"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Aye</surname> <given-names>Y</given-names></name><name><surname>Li</surname> <given-names>M</given-names></name><name><surname>Long</surname> <given-names>MJ</given-names></name><name><surname>Weiss</surname> <given-names>RS</given-names></name></person-group><year iso-8601-date="2015">2015</year><article-title>Ribonucleotide reductase and cancer: biological mechanisms and targeted therapies</article-title><source>Oncogene</source><volume>34</volume><fpage>2011</fpage><lpage>2021</lpage><pub-id pub-id-type="doi">10.1038/onc.2014.155</pub-id><pub-id pub-id-type="pmid">24909171</pub-id></element-citation></ref><ref id="bib9"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Aye</surname> <given-names>Y</given-names></name><name><surname>Stubbe</surname> <given-names>J</given-names></name></person-group><year iso-8601-date="2011">2011</year><article-title>Clofarabine 5'-di and -triphosphates inhibit human ribonucleotide reductase by altering the quaternary structure of its large subunit</article-title><source>PNAS</source><volume>108</volume><fpage>9815</fpage><lpage>9820</lpage><pub-id pub-id-type="doi">10.1073/pnas.1013274108</pub-id><pub-id pub-id-type="pmid">21628579</pub-id></element-citation></ref><ref id="bib10"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bochner</surname> <given-names>BR</given-names></name><name><surname>Ames</surname> <given-names>BN</given-names></name></person-group><year iso-8601-date="1982">1982</year><article-title>Complete analysis of cellular nucleotides by two-dimensional thin layer chromatography</article-title><source>The Journal of Biological Chemistry</source><volume>257</volume><fpage>9759</fpage><lpage>9769</lpage><pub-id pub-id-type="pmid">6286632</pub-id></element-citation></ref><ref id="bib11"><element-citation publication-type="software"><person-group person-group-type="author"><name><surname>Bricogne</surname> <given-names>GB</given-names></name><name><surname>Brandl</surname> <given-names>E</given-names></name><name><surname>Flensburg</surname> <given-names>M</given-names></name><name><surname>Keller</surname> <given-names>C</given-names></name><name><surname>Paciorek</surname> <given-names>P</given-names></name><name><surname>Roversi</surname> <given-names>W</given-names></name><name><surname>Sharff</surname> <given-names>P</given-names></name><name><surname>Smart</surname> <given-names>A</given-names></name><name><surname>Vonrhein</surname> <given-names>OS</given-names></name><name><surname>Womack</surname> <given-names>TO</given-names></name></person-group><year iso-8601-date="2016">2016</year><data-title>BUSTER</data-title><version designator="2.10.2">2.10.2</version><publisher-loc>Cambridge, United Kingdom</publisher-loc><publisher-name>Global Phasing Ltd</publisher-name></element-citation></ref><ref id="bib12"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Brown</surname> <given-names>NC</given-names></name><name><surname>Reichard</surname> <given-names>P</given-names></name></person-group><year iso-8601-date="1969">1969</year><article-title>Role of effector binding in allosteric control of ribonucleoside diphosphate reductase</article-title><source>Journal of Molecular Biology</source><volume>46</volume><fpage>39</fpage><lpage>55</lpage><pub-id pub-id-type="doi">10.1016/0022-2836(69)90056-4</pub-id><pub-id pub-id-type="pmid">4902212</pub-id></element-citation></ref><ref id="bib13"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Buckstein</surname> <given-names>MH</given-names></name><name><surname>He</surname> <given-names>J</given-names></name><name><surname>Rubin</surname> <given-names>H</given-names></name></person-group><year iso-8601-date="2008">2008</year><article-title>Characterization of nucleotide pools as a function of physiological state in Escherichia coli</article-title><source>Journal of Bacteriology</source><volume>190</volume><fpage>718</fpage><lpage>726</lpage><pub-id pub-id-type="doi">10.1128/JB.01020-07</pub-id><pub-id pub-id-type="pmid">17965154</pub-id></element-citation></ref><ref id="bib14"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Chen</surname> <given-names>VB</given-names></name><name><surname>Arendall</surname> <given-names>WB</given-names></name><name><surname>Headd</surname> <given-names>JJ</given-names></name><name><surname>Keedy</surname> <given-names>DA</given-names></name><name><surname>Immormino</surname> <given-names>RM</given-names></name><name><surname>Kapral</surname> <given-names>GJ</given-names></name><name><surname>Murray</surname> <given-names>LW</given-names></name><name><surname>Richardson</surname> <given-names>JS</given-names></name><name><surname>Richardson</surname> <given-names>DC</given-names></name></person-group><year iso-8601-date="2010">2010</year><article-title>MolProbity: all-atom structure validation for macromolecular crystallography</article-title><source>Acta Crystallographica Section D Biological Crystallography</source><volume>66</volume><fpage>12</fpage><lpage>21</lpage><pub-id pub-id-type="doi">10.1107/S0907444909042073</pub-id><pub-id pub-id-type="pmid">20057044</pub-id></element-citation></ref><ref id="bib15"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Cotruvo</surname> <given-names>JA</given-names></name><name><surname>Stich</surname> <given-names>TA</given-names></name><name><surname>Britt</surname> <given-names>RD</given-names></name><name><surname>Stubbe</surname> <given-names>J</given-names></name></person-group><year iso-8601-date="2013">2013</year><article-title>Mechanism of assembly of the dimanganese-tyrosyl radical cofactor of class Ib ribonucleotide reductase: enzymatic generation of superoxide is required for tyrosine oxidation via a Mn(III)Mn(IV) intermediate</article-title><source>Journal of the American Chemical Society</source><volume>135</volume><fpage>4027</fpage><lpage>4039</lpage><pub-id pub-id-type="doi">10.1021/ja312457t</pub-id><pub-id pub-id-type="pmid">23402532</pub-id></element-citation></ref><ref id="bib16"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Cotruvo</surname> <given-names>JA</given-names></name><name><surname>Stubbe</surname> <given-names>J</given-names></name></person-group><year iso-8601-date="2012">2012</year><article-title>Metallation and mismetallation of iron and manganese proteins in vitro and in vivo: the class I ribonucleotide reductases as a case study</article-title><source>Metallomics</source><volume>4</volume><fpage>1020</fpage><lpage>1036</lpage><pub-id pub-id-type="doi">10.1039/c2mt20142a</pub-id><pub-id pub-id-type="pmid">22991063</pub-id></element-citation></ref><ref id="bib17"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Cowtan</surname> <given-names>K</given-names></name></person-group><year iso-8601-date="2006">2006</year><article-title>The Buccaneer software for automated model building. 1. Tracing protein chains</article-title><source>Acta Crystallographica Section D Biological Crystallography</source><volume>62</volume><fpage>1002</fpage><lpage>1011</lpage><pub-id pub-id-type="doi">10.1107/S0907444906022116</pub-id><pub-id pub-id-type="pmid">16929101</pub-id></element-citation></ref><ref id="bib18"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Crona</surname> <given-names>M</given-names></name><name><surname>Avesson</surname> <given-names>L</given-names></name><name><surname>Sahlin</surname> <given-names>M</given-names></name><name><surname>Lundin</surname> <given-names>D</given-names></name><name><surname>Hinas</surname> <given-names>A</given-names></name><name><surname>Klose</surname> <given-names>R</given-names></name><name><surname>Söderbom</surname> <given-names>F</given-names></name><name><surname>Sjöberg</surname> <given-names>BM</given-names></name></person-group><year iso-8601-date="2013">2013</year><article-title>A rare combination of ribonucleotide reductases in the social amoeba Dictyostelium discoideum</article-title><source>Journal of Biological Chemistry</source><volume>288</volume><fpage>8198</fpage><lpage>8208</lpage><pub-id pub-id-type="doi">10.1074/jbc.M112.442434</pub-id><pub-id pub-id-type="pmid">23372162</pub-id></element-citation></ref><ref id="bib19"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Cross</surname> <given-names>PJ</given-names></name><name><surname>Allison</surname> <given-names>TM</given-names></name><name><surname>Dobson</surname> <given-names>RC</given-names></name><name><surname>Jameson</surname> <given-names>GB</given-names></name><name><surname>Parker</surname> <given-names>EJ</given-names></name></person-group><year iso-8601-date="2013">2013</year><article-title>Engineering allosteric control to an unregulated enzyme by transfer of a regulatory domain</article-title><source>PNAS</source><volume>110</volume><fpage>2111</fpage><lpage>2116</lpage><pub-id pub-id-type="doi">10.1073/pnas.1217923110</pub-id><pub-id pub-id-type="pmid">23345433</pub-id></element-citation></ref><ref id="bib20"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Do</surname> <given-names>CB</given-names></name><name><surname>Mahabhashyam</surname> <given-names>MS</given-names></name><name><surname>Brudno</surname> <given-names>M</given-names></name><name><surname>Batzoglou</surname> <given-names>S</given-names></name></person-group><year iso-8601-date="2005">2005</year><article-title>ProbCons: Probabilistic consistency-based multiple sequence alignment</article-title><source>Genome Research</source><volume>15</volume><fpage>330</fpage><lpage>340</lpage><pub-id pub-id-type="doi">10.1101/gr.2821705</pub-id><pub-id pub-id-type="pmid">15687296</pub-id></element-citation></ref><ref id="bib21"><element-citation publication-type="book"><person-group person-group-type="author"><name><surname>Berggren</surname> <given-names>G</given-names></name><name><surname>Lundin</surname> <given-names>D</given-names></name><name><surname>Sjöberg</surname> <given-names>B-M</given-names></name></person-group><year iso-8601-date="2017">2017</year><chapter-title>Homo- and heterometallic dinuclear manganese proteins: active site assembly</chapter-title><person-group person-group-type="editor"><name><surname>Johnson</surname> <given-names>M. K</given-names></name><name><surname>Scott</surname> <given-names>R. A</given-names></name></person-group><source>Metalloprotein Active Site Assembly</source><publisher-loc>Chichester, UK</publisher-loc><publisher-name>John Wiley &amp; Sons, Ltd</publisher-name></element-citation></ref><ref id="bib22"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Eddy</surname> <given-names>SR</given-names></name></person-group><year iso-8601-date="2011">2011</year><article-title>Accelerated profile hmm searches</article-title><source>PLoS Computational Biology</source><volume>7</volume><elocation-id>e1002195</elocation-id><pub-id pub-id-type="doi">10.1371/journal.pcbi.1002195</pub-id><pub-id pub-id-type="pmid">22039361</pub-id></element-citation></ref><ref id="bib23"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Emsley</surname> <given-names>P</given-names></name><name><surname>Lohkamp</surname> <given-names>B</given-names></name><name><surname>Scott</surname> <given-names>WG</given-names></name><name><surname>Cowtan</surname> <given-names>K</given-names></name></person-group><year iso-8601-date="2010">2010</year><article-title>Features and development of Coot</article-title><source>Acta Crystallographica Section D Biological Crystallography</source><volume>66</volume><fpage>486</fpage><lpage>501</lpage><pub-id pub-id-type="doi">10.1107/S0907444910007493</pub-id><pub-id pub-id-type="pmid">20383002</pub-id></element-citation></ref><ref id="bib24"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Eriksson</surname> <given-names>M</given-names></name><name><surname>Uhlin</surname> <given-names>U</given-names></name><name><surname>Ramaswamy</surname> <given-names>S</given-names></name><name><surname>Ekberg</surname> <given-names>M</given-names></name><name><surname>Regnström</surname> <given-names>K</given-names></name><name><surname>Sjöberg</surname> <given-names>BM</given-names></name><name><surname>Eklund</surname> <given-names>H</given-names></name></person-group><year iso-8601-date="1997">1997</year><article-title>Binding of allosteric effectors to ribonucleotide reductase protein R1: reduction of active-site cysteines promotes substrate binding</article-title><source>Structure</source><volume>5</volume><fpage>1077</fpage><lpage>1092</lpage><pub-id pub-id-type="doi">10.1016/S0969-2126(97)00259-1</pub-id><pub-id pub-id-type="pmid">9309223</pub-id></element-citation></ref><ref id="bib25"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Evans</surname> <given-names>PR</given-names></name><name><surname>Murshudov</surname> <given-names>GN</given-names></name></person-group><year iso-8601-date="2013">2013</year><article-title>How good are my data and what is the resolution?</article-title><source>Acta Crystallographica Section D Biological Crystallography</source><volume>69</volume><fpage>1204</fpage><lpage>1214</lpage><pub-id pub-id-type="doi">10.1107/S0907444913000061</pub-id><pub-id pub-id-type="pmid">23793146</pub-id></element-citation></ref><ref id="bib26"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Fairman</surname> <given-names>JW</given-names></name><name><surname>Wijerathna</surname> <given-names>SR</given-names></name><name><surname>Ahmad</surname> <given-names>MF</given-names></name><name><surname>Xu</surname> <given-names>H</given-names></name><name><surname>Nakano</surname> <given-names>R</given-names></name><name><surname>Jha</surname> <given-names>S</given-names></name><name><surname>Prendergast</surname> <given-names>J</given-names></name><name><surname>Welin</surname> <given-names>RM</given-names></name><name><surname>Flodin</surname> <given-names>S</given-names></name><name><surname>Roos</surname> <given-names>A</given-names></name><name><surname>Nordlund</surname> <given-names>P</given-names></name><name><surname>Li</surname> <given-names>Z</given-names></name><name><surname>Walz</surname> <given-names>T</given-names></name><name><surname>Dealwis</surname> <given-names>CG</given-names></name></person-group><year iso-8601-date="2011">2011</year><article-title>Structural basis for allosteric regulation of human ribonucleotide reductase by nucleotide-induced oligomerization</article-title><source>Nature Structural &amp; Molecular Biology</source><volume>18</volume><fpage>316</fpage><lpage>322</lpage><pub-id pub-id-type="doi">10.1038/nsmb.2007</pub-id><pub-id pub-id-type="pmid">21336276</pub-id></element-citation></ref><ref id="bib27"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Fernández-Gómez</surname> <given-names>B</given-names></name><name><surname>Richter</surname> <given-names>M</given-names></name><name><surname>Schüler</surname> <given-names>M</given-names></name><name><surname>Pinhassi</surname> <given-names>J</given-names></name><name><surname>Acinas</surname> <given-names>SG</given-names></name><name><surname>González</surname> <given-names>JM</given-names></name><name><surname>Pedrós-Alió</surname> <given-names>C</given-names></name></person-group><year iso-8601-date="2013">2013</year><article-title>Ecology of marine bacteroidetes: a comparative genomics approach</article-title><source>The ISME Journal</source><volume>7</volume><fpage>1026</fpage><lpage>1037</lpage><pub-id pub-id-type="doi">10.1038/ismej.2012.169</pub-id><pub-id pub-id-type="pmid">23303374</pub-id></element-citation></ref><ref id="bib28"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Finn</surname> <given-names>RD</given-names></name><name><surname>Mistry</surname> <given-names>J</given-names></name><name><surname>Tate</surname> <given-names>J</given-names></name><name><surname>Coggill</surname> <given-names>P</given-names></name><name><surname>Heger</surname> <given-names>A</given-names></name><name><surname>Pollington</surname> <given-names>JE</given-names></name><name><surname>Gavin</surname> <given-names>OL</given-names></name><name><surname>Gunasekaran</surname> <given-names>P</given-names></name><name><surname>Ceric</surname> <given-names>G</given-names></name><name><surname>Forslund</surname> <given-names>K</given-names></name><name><surname>Holm</surname> <given-names>L</given-names></name><name><surname>Sonnhammer</surname> <given-names>EL</given-names></name><name><surname>Eddy</surname> <given-names>SR</given-names></name><name><surname>Bateman</surname> <given-names>A</given-names></name></person-group><year iso-8601-date="2010">2010</year><article-title>The Pfam protein families database</article-title><source>Nucleic Acids Research</source><volume>38</volume><fpage>D211</fpage><lpage>D222</lpage><pub-id pub-id-type="doi">10.1093/nar/gkp985</pub-id><pub-id pub-id-type="pmid">19920124</pub-id></element-citation></ref><ref id="bib29"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Griese</surname> <given-names>JJ</given-names></name><name><surname>Srinivas</surname> <given-names>V</given-names></name><name><surname>Högbom</surname> <given-names>M</given-names></name></person-group><year iso-8601-date="2014">2014</year><article-title>Assembly of nonheme Mn/Fe active sites in heterodinuclear metalloproteins</article-title><source>JBIC Journal of Biological Inorganic Chemistry</source><volume>19</volume><fpage>759</fpage><lpage>774</lpage><pub-id pub-id-type="doi">10.1007/s00775-014-1140-7</pub-id><pub-id pub-id-type="pmid">24771036</pub-id></element-citation></ref><ref id="bib30"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Grinberg</surname> <given-names>I</given-names></name><name><surname>Shteinberg</surname> <given-names>T</given-names></name><name><surname>Gorovitz</surname> <given-names>B</given-names></name><name><surname>Aharonowitz</surname> <given-names>Y</given-names></name><name><surname>Cohen</surname> <given-names>G</given-names></name><name><surname>Borovok</surname> <given-names>I</given-names></name></person-group><year iso-8601-date="2006">2006</year><article-title>The Streptomyces NrdR transcriptional regulator is a Zn ribbon/ATP cone protein that binds to the promoter regions of class Ia and class II ribonucleotide reductase operons</article-title><source>Journal of Bacteriology</source><volume>188</volume><fpage>7635</fpage><lpage>7644</lpage><pub-id pub-id-type="doi">10.1128/JB.00903-06</pub-id><pub-id pub-id-type="pmid">16950922</pub-id></element-citation></ref><ref id="bib31"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gunasekaran</surname> <given-names>K</given-names></name><name><surname>Ma</surname> <given-names>B</given-names></name><name><surname>Nussinov</surname> <given-names>R</given-names></name></person-group><year iso-8601-date="2004">2004</year><article-title>Is allostery an intrinsic property of all dynamic proteins?</article-title><source>Proteins: Structure, Function, and Bioinformatics</source><volume>57</volume><fpage>433</fpage><lpage>443</lpage><pub-id pub-id-type="doi">10.1002/prot.20232</pub-id><pub-id pub-id-type="pmid">15382234</pub-id></element-citation></ref><ref id="bib32"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hofer</surname> <given-names>A</given-names></name><name><surname>Crona</surname> <given-names>M</given-names></name><name><surname>Logan</surname> <given-names>DT</given-names></name><name><surname>Sjöberg</surname> <given-names>BM</given-names></name></person-group><year iso-8601-date="2012">2012</year><article-title>DNA building blocks: keeping control of manufacture</article-title><source>Critical Reviews in Biochemistry and Molecular Biology</source><volume>47</volume><fpage>50</fpage><lpage>63</lpage><pub-id pub-id-type="doi">10.3109/10409238.2011.630372</pub-id><pub-id pub-id-type="pmid">22050358</pub-id></element-citation></ref><ref id="bib33"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Högbom</surname> <given-names>M</given-names></name><name><surname>Stenmark</surname> <given-names>P</given-names></name><name><surname>Voevodskaya</surname> <given-names>N</given-names></name><name><surname>McClarty</surname> <given-names>G</given-names></name><name><surname>Gräslund</surname> <given-names>A</given-names></name><name><surname>Nordlund</surname> <given-names>P</given-names></name></person-group><year iso-8601-date="2004">2004</year><article-title>The radical site in chlamydial ribonucleotide reductase defines a new R2 subclass</article-title><source>Science</source><volume>305</volume><fpage>245</fpage><lpage>248</lpage><pub-id pub-id-type="doi">10.1126/science.1098419</pub-id><pub-id pub-id-type="pmid">15247479</pub-id></element-citation></ref><ref id="bib34"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Huang</surname> <given-names>M</given-names></name><name><surname>Parker</surname> <given-names>MJ</given-names></name><name><surname>Stubbe</surname> <given-names>J</given-names></name></person-group><year iso-8601-date="2014">2014</year><article-title>Choosing the right metal: case studies of class I ribonucleotide reductases</article-title><source>Journal of Biological Chemistry</source><volume>289</volume><fpage>28104</fpage><lpage>28111</lpage><pub-id pub-id-type="doi">10.1074/jbc.R114.596684</pub-id><pub-id pub-id-type="pmid">25160629</pub-id></element-citation></ref><ref id="bib35"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Johansson</surname> <given-names>R</given-names></name><name><surname>Jonna</surname> <given-names>VR</given-names></name><name><surname>Kumar</surname> <given-names>R</given-names></name><name><surname>Nayeri</surname> <given-names>N</given-names></name><name><surname>Lundin</surname> <given-names>D</given-names></name><name><surname>Sjöberg</surname> <given-names>BM</given-names></name><name><surname>Hofer</surname> <given-names>A</given-names></name><name><surname>Logan</surname> <given-names>DT</given-names></name></person-group><year iso-8601-date="2016">2016</year><article-title>Structural mechanism of allosteric activity regulation in a ribonucleotide reductase with double ATP cones</article-title><source>Structure</source><volume>24</volume><fpage>906</fpage><lpage>917</lpage><pub-id pub-id-type="doi">10.1016/j.str.2016.03.025</pub-id><pub-id pub-id-type="pmid">27133024</pub-id></element-citation></ref><ref id="bib36"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Jonna</surname> <given-names>VR</given-names></name><name><surname>Crona</surname> <given-names>M</given-names></name><name><surname>Rofougaran</surname> <given-names>R</given-names></name><name><surname>Lundin</surname> <given-names>D</given-names></name><name><surname>Johansson</surname> <given-names>S</given-names></name><name><surname>Brännström</surname> <given-names>K</given-names></name><name><surname>Sjöberg</surname> <given-names>BM</given-names></name><name><surname>Hofer</surname> <given-names>A</given-names></name></person-group><year iso-8601-date="2015">2015</year><article-title>Diversity in overall activity regulation of ribonucleotide reductase</article-title><source>Journal of Biological Chemistry</source><volume>290</volume><fpage>17339</fpage><lpage>17348</lpage><pub-id pub-id-type="doi">10.1074/jbc.M115.649624</pub-id><pub-id pub-id-type="pmid">25971975</pub-id></element-citation></ref><ref id="bib37"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Julián</surname> <given-names>E</given-names></name><name><surname>Baelo</surname> <given-names>A</given-names></name><name><surname>Gavaldà</surname> <given-names>J</given-names></name><name><surname>Torrents</surname> <given-names>E</given-names></name></person-group><year iso-8601-date="2015">2015</year><article-title>Methyl-hydroxylamine as an efficacious antibacterial agent that targets the ribonucleotide reductase enzyme</article-title><source>PLoS One</source><volume>10</volume><elocation-id>e0122049</elocation-id><pub-id pub-id-type="doi">10.1371/journal.pone.0122049</pub-id><pub-id pub-id-type="pmid">25782003</pub-id></element-citation></ref><ref id="bib38"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kabsch</surname> <given-names>W</given-names></name></person-group><year iso-8601-date="2010">2010</year><article-title>XDS</article-title><source>Acta crystallographica. Section D, Biological crystallography</source><volume>66</volume><fpage>125</fpage><lpage>132</lpage><pub-id pub-id-type="doi">10.1107/S0907444909047337</pub-id><pub-id pub-id-type="pmid">20124692</pub-id></element-citation></ref><ref id="bib39"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kashlan</surname> <given-names>OB</given-names></name><name><surname>Scott</surname> <given-names>CP</given-names></name><name><surname>Lear</surname> <given-names>JD</given-names></name><name><surname>Cooperman</surname> <given-names>BS</given-names></name></person-group><year iso-8601-date="2002">2002</year><article-title>A comprehensive model for the allosteric regulation of mammalian ribonucleotide reductase. Functional consequences of ATP- and dATP-induced oligomerization of the large subunit</article-title><source>Biochemistry</source><volume>41</volume><fpage>462</fpage><lpage>474</lpage><pub-id pub-id-type="doi">10.1021/bi011653a</pub-id><pub-id pub-id-type="pmid">11781084</pub-id></element-citation></ref><ref id="bib40"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kaufman</surname> <given-names>SL</given-names></name><name><surname>Skogen</surname> <given-names>JW</given-names></name><name><surname>Dorman</surname> <given-names>FD</given-names></name><name><surname>Zarrin</surname> <given-names>F</given-names></name><name><surname>Lewis</surname> <given-names>KC</given-names></name></person-group><year iso-8601-date="1996">1996</year><article-title>Macromolecule analysis based on electrophoretic mobility in air: globular proteins</article-title><source>Analytical Chemistry</source><volume>68</volume><fpage>1895</fpage><lpage>1904</lpage><pub-id pub-id-type="doi">10.1021/ac951128f</pub-id><pub-id pub-id-type="pmid">21619100</pub-id></element-citation></ref><ref id="bib41"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kumar</surname> <given-names>D</given-names></name><name><surname>Abdulovic</surname> <given-names>AL</given-names></name><name><surname>Viberg</surname> <given-names>J</given-names></name><name><surname>Nilsson</surname> <given-names>AK</given-names></name><name><surname>Kunkel</surname> <given-names>TA</given-names></name><name><surname>Chabes</surname> <given-names>A</given-names></name></person-group><year iso-8601-date="2011">2011</year><article-title>Mechanisms of mutagenesis in vivo due to imbalanced dNTP pools</article-title><source>Nucleic Acids Research</source><volume>39</volume><fpage>1360</fpage><lpage>1371</lpage><pub-id pub-id-type="doi">10.1093/nar/gkq829</pub-id><pub-id pub-id-type="pmid">20961955</pub-id></element-citation></ref><ref id="bib42"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lang</surname> <given-names>EJ</given-names></name><name><surname>Cross</surname> <given-names>PJ</given-names></name><name><surname>Mittelstädt</surname> <given-names>G</given-names></name><name><surname>Jameson</surname> <given-names>GB</given-names></name><name><surname>Parker</surname> <given-names>EJ</given-names></name></person-group><year iso-8601-date="2014">2014</year><article-title>Allosteric ACTion: the varied ACT domains regulating enzymes of amino-acid metabolism</article-title><source>Current Opinion in Structural Biology</source><volume>29</volume><fpage>102</fpage><lpage>111</lpage><pub-id pub-id-type="doi">10.1016/j.sbi.2014.10.007</pub-id><pub-id pub-id-type="pmid">25543886</pub-id></element-citation></ref><ref id="bib43"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Larsson</surname> <given-names>KM</given-names></name><name><surname>Jordan</surname> <given-names>A</given-names></name><name><surname>Eliasson</surname> <given-names>R</given-names></name><name><surname>Reichard</surname> <given-names>P</given-names></name><name><surname>Logan</surname> <given-names>DT</given-names></name><name><surname>Nordlund</surname> <given-names>P</given-names></name></person-group><year iso-8601-date="2004">2004</year><article-title>Structural mechanism of allosteric substrate specificity regulation in a ribonucleotide reductase</article-title><source>Nature Structural &amp; Molecular Biology</source><volume>11</volume><fpage>1142</fpage><lpage>1149</lpage><pub-id pub-id-type="doi">10.1038/nsmb838</pub-id><pub-id pub-id-type="pmid">15475969</pub-id></element-citation></ref><ref id="bib44"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lundin</surname> <given-names>D</given-names></name><name><surname>Berggren</surname> <given-names>G</given-names></name><name><surname>Logan</surname> <given-names>DT</given-names></name><name><surname>Sjöberg</surname> <given-names>BM</given-names></name></person-group><year iso-8601-date="2015">2015</year><article-title>The origin and evolution of ribonucleotide reduction</article-title><source>Life</source><volume>5</volume><fpage>604</fpage><lpage>636</lpage><pub-id pub-id-type="doi">10.3390/life5010604</pub-id><pub-id pub-id-type="pmid">25734234</pub-id></element-citation></ref><ref id="bib45"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mathews</surname> <given-names>CK</given-names></name></person-group><year iso-8601-date="2006">2006</year><article-title>DNA precursor metabolism and genomic stability</article-title><source>The FASEB Journal</source><volume>20</volume><fpage>1300</fpage><lpage>1314</lpage><pub-id pub-id-type="doi">10.1096/fj.06-5730rev</pub-id><pub-id pub-id-type="pmid">16816105</pub-id></element-citation></ref><ref id="bib46"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mathews</surname> <given-names>CK</given-names></name></person-group><year iso-8601-date="2014">2014</year><article-title>Deoxyribonucleotides as genetic and metabolic regulators</article-title><source>The FASEB Journal</source><volume>28</volume><fpage>3832</fpage><lpage>3840</lpage><pub-id pub-id-type="doi">10.1096/fj.14-251249</pub-id><pub-id pub-id-type="pmid">24928192</pub-id></element-citation></ref><ref id="bib47"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>McCoy</surname> <given-names>AJ</given-names></name><name><surname>Grosse-Kunstleve</surname> <given-names>RW</given-names></name><name><surname>Adams</surname> <given-names>PD</given-names></name><name><surname>Winn</surname> <given-names>MD</given-names></name><name><surname>Storoni</surname> <given-names>LC</given-names></name><name><surname>Read</surname> <given-names>RJ</given-names></name></person-group><year iso-8601-date="2007">2007</year><article-title>Phaser crystallographic software</article-title><source>Journal of Applied Crystallography</source><volume>40</volume><fpage>658</fpage><lpage>674</lpage><pub-id pub-id-type="doi">10.1107/S0021889807021206</pub-id><pub-id pub-id-type="pmid">19461840</pub-id></element-citation></ref><ref id="bib48"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>McKethan</surname> <given-names>BL</given-names></name><name><surname>Spiro</surname> <given-names>S</given-names></name></person-group><year iso-8601-date="2013">2013</year><article-title>Cooperative and allosterically controlled nucleotide binding regulates the DNA binding activity of NrdR</article-title><source>Molecular Microbiology</source><volume>90</volume><fpage>n/a</fpage><lpage>289</lpage><pub-id pub-id-type="doi">10.1111/mmi.12364</pub-id><pub-id pub-id-type="pmid">23941567</pub-id></element-citation></ref><ref id="bib49"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Murshudov</surname> <given-names>GN</given-names></name><name><surname>Vagin</surname> <given-names>AA</given-names></name><name><surname>Dodson</surname> <given-names>EJ</given-names></name></person-group><year iso-8601-date="1997">1997</year><article-title>Refinement of macromolecular structures by the maximum-likelihood method</article-title><source>Acta Crystallographica Section D Biological Crystallography</source><volume>53</volume><fpage>240</fpage><lpage>255</lpage><pub-id pub-id-type="doi">10.1107/S0907444996012255</pub-id><pub-id pub-id-type="pmid">15299926</pub-id></element-citation></ref><ref id="bib50"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Nordlund</surname> <given-names>P</given-names></name><name><surname>Reichard</surname> <given-names>P</given-names></name></person-group><year iso-8601-date="2006">2006</year><article-title>Ribonucleotide reductases</article-title><source>Annual Review of Biochemistry</source><volume>75</volume><fpage>681</fpage><lpage>706</lpage><pub-id pub-id-type="doi">10.1146/annurev.biochem.75.103004.142443</pub-id><pub-id pub-id-type="pmid">16756507</pub-id></element-citation></ref><ref id="bib51"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Nussinov</surname> <given-names>R</given-names></name><name><surname>Tsai</surname> <given-names>CJ</given-names></name></person-group><year iso-8601-date="2013">2013</year><article-title>Allostery in disease and in drug discovery</article-title><source>Cell</source><volume>153</volume><fpage>293</fpage><lpage>305</lpage><pub-id pub-id-type="doi">10.1016/j.cell.2013.03.034</pub-id><pub-id pub-id-type="pmid">23582321</pub-id></element-citation></ref><ref id="bib52"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Pai</surname> <given-names>CC</given-names></name><name><surname>Kearsey</surname> <given-names>SE</given-names></name></person-group><year iso-8601-date="2017">2017</year><article-title>A critical balance: dntps and the maintenance of genome stability</article-title><source>Genes</source><volume>8</volume><fpage>57</fpage><pub-id pub-id-type="doi">10.3390/genes8020057</pub-id><pub-id pub-id-type="pmid">28146119</pub-id></element-citation></ref><ref id="bib53"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Pinhassi</surname> <given-names>J</given-names></name><name><surname>Bowman</surname> <given-names>JP</given-names></name><name><surname>Nedashkovskaya</surname> <given-names>OI</given-names></name><name><surname>Lekunberri</surname> <given-names>I</given-names></name><name><surname>Gomez-Consarnau</surname> <given-names>L</given-names></name><name><surname>Pedrós-Alió</surname> <given-names>C</given-names></name></person-group><year iso-8601-date="2006">2006</year><article-title>Leeuwenhoekiella blandensis sp. nov., a genome-sequenced marine member of the family Flavobacteriaceae</article-title><source>International Journal Of Systematic And Evolutionary Microbiology</source><volume>56</volume><fpage>1489</fpage><lpage>1493</lpage><pub-id pub-id-type="doi">10.1099/ijs.0.64232-0</pub-id><pub-id pub-id-type="pmid">16825617</pub-id></element-citation></ref><ref id="bib54"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Price</surname> <given-names>MN</given-names></name><name><surname>Dehal</surname> <given-names>PS</given-names></name><name><surname>Arkin</surname> <given-names>AP</given-names></name></person-group><year iso-8601-date="2010">2010</year><article-title>FastTree 2--approximately maximum-likelihood trees for large alignments</article-title><source>PLoS One</source><volume>5</volume><elocation-id>e9490</elocation-id><pub-id pub-id-type="doi">10.1371/journal.pone.0009490</pub-id><pub-id pub-id-type="pmid">20224823</pub-id></element-citation></ref><ref id="bib55"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Reichard</surname> <given-names>P</given-names></name></person-group><year iso-8601-date="2010">2010</year><article-title>Ribonucleotide reductases: substrate specificity by allostery</article-title><source>Biochemical and Biophysical Research Communications</source><volume>396</volume><fpage>19</fpage><lpage>23</lpage><pub-id pub-id-type="doi">10.1016/j.bbrc.2010.02.108</pub-id><pub-id pub-id-type="pmid">20494104</pub-id></element-citation></ref><ref id="bib56"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Rofougaran</surname> <given-names>R</given-names></name><name><surname>Crona</surname> <given-names>M</given-names></name><name><surname>Vodnala</surname> <given-names>M</given-names></name><name><surname>Sjöberg</surname> <given-names>BM</given-names></name><name><surname>Hofer</surname> <given-names>A</given-names></name></person-group><year iso-8601-date="2008">2008</year><article-title>Oligomerization status directs overall activity regulation of the Escherichia coli class Ia ribonucleotide reductase</article-title><source>Journal of Biological Chemistry</source><volume>283</volume><fpage>35310</fpage><lpage>35318</lpage><pub-id pub-id-type="doi">10.1074/jbc.M806738200</pub-id><pub-id pub-id-type="pmid">18835811</pub-id></element-citation></ref><ref id="bib57"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Rofougaran</surname> <given-names>R</given-names></name><name><surname>Vodnala</surname> <given-names>M</given-names></name><name><surname>Hofer</surname> <given-names>A</given-names></name></person-group><year iso-8601-date="2006">2006</year><article-title>Enzymatically active mammalian ribonucleotide reductase exists primarily as an alpha6beta2 octamer</article-title><source>The Journal of Biological Chemistry</source><volume>281</volume><fpage>27705</fpage><lpage>27711</lpage><pub-id pub-id-type="doi">10.1074/jbc.M605573200</pub-id><pub-id pub-id-type="pmid">16861739</pub-id></element-citation></ref><ref id="bib58"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Rognes</surname> <given-names>T</given-names></name><name><surname>Flouri</surname> <given-names>T</given-names></name><name><surname>Nichols</surname> <given-names>B</given-names></name><name><surname>Quince</surname> <given-names>C</given-names></name><name><surname>Mahé</surname> <given-names>F</given-names></name></person-group><year iso-8601-date="2016">2016</year><article-title>VSEARCH: a versatile open source tool for metagenomics</article-title><source>PeerJ</source><volume>4</volume><elocation-id>e2584</elocation-id><pub-id pub-id-type="doi">10.7717/peerj.2584</pub-id><pub-id pub-id-type="pmid">27781170</pub-id></element-citation></ref><ref id="bib59"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Roos</surname> <given-names>K</given-names></name><name><surname>Siegbahn</surname> <given-names>PE</given-names></name></person-group><year iso-8601-date="2011">2011</year><article-title>Oxygen cleavage with manganese and iron in ribonucleotide reductase from Chlamydia trachomatis</article-title><source>JBIC Journal of Biological Inorganic Chemistry</source><volume>16</volume><fpage>553</fpage><lpage>565</lpage><pub-id pub-id-type="doi">10.1007/s00775-011-0755-1</pub-id><pub-id pub-id-type="pmid">21258828</pub-id></element-citation></ref><ref id="bib60"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Stein</surname> <given-names>N</given-names></name></person-group><year iso-8601-date="2008">2008</year><article-title>CHAINSAW : a program for mutating pdb files used as templates in molecular replacement</article-title><source>Journal of Applied Crystallography</source><volume>41</volume><fpage>641</fpage><lpage>643</lpage><pub-id pub-id-type="doi">10.1107/S0021889808006985</pub-id></element-citation></ref><ref id="bib61"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Swain</surname> <given-names>JF</given-names></name><name><surname>Gierasch</surname> <given-names>LM</given-names></name></person-group><year iso-8601-date="2006">2006</year><article-title>The changing landscape of protein allostery</article-title><source>Current Opinion in Structural Biology</source><volume>16</volume><fpage>102</fpage><lpage>108</lpage><pub-id pub-id-type="doi">10.1016/j.sbi.2006.01.003</pub-id><pub-id pub-id-type="pmid">16423525</pub-id></element-citation></ref><ref id="bib62"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Thelander</surname> <given-names>L</given-names></name><name><surname>Reichard</surname> <given-names>P</given-names></name></person-group><year iso-8601-date="1979">1979</year><article-title>Reduction of ribonucleotides</article-title><source>Annual Review of Biochemistry</source><volume>48</volume><fpage>133</fpage><lpage>158</lpage><pub-id pub-id-type="doi">10.1146/annurev.bi.48.070179.001025</pub-id><pub-id pub-id-type="pmid">382982</pub-id></element-citation></ref><ref id="bib63"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Tholander</surname> <given-names>F</given-names></name><name><surname>Sjöberg</surname> <given-names>BM</given-names></name></person-group><year iso-8601-date="2012">2012</year><article-title>Discovery of antimicrobial ribonucleotide reductase inhibitors by screening in microwell format</article-title><source>PNAS</source><volume>109</volume><fpage>9798</fpage><lpage>9803</lpage><pub-id pub-id-type="doi">10.1073/pnas.1113051109</pub-id><pub-id pub-id-type="pmid">22665797</pub-id></element-citation></ref><ref id="bib64"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Torrents</surname> <given-names>E</given-names></name><name><surname>Buist</surname> <given-names>G</given-names></name><name><surname>Liu</surname> <given-names>A</given-names></name><name><surname>Eliasson</surname> <given-names>R</given-names></name><name><surname>Kok</surname> <given-names>J</given-names></name><name><surname>Gibert</surname> <given-names>I</given-names></name><name><surname>Gräslund</surname> <given-names>A</given-names></name><name><surname>Reichard</surname> <given-names>P</given-names></name></person-group><year iso-8601-date="2000">2000</year><article-title>The anaerobic (class III) ribonucleotide reductase from lactococcus lactis. catalytic properties and allosteric regulation of the pure enzyme system</article-title><source>The Journal of Biological Chemistry</source><volume>275</volume><fpage>2463</fpage><lpage>2471</lpage><pub-id pub-id-type="pmid">10644700</pub-id></element-citation></ref><ref id="bib65"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Torrents</surname> <given-names>E</given-names></name><name><surname>Westman</surname> <given-names>M</given-names></name><name><surname>Sahlin</surname> <given-names>M</given-names></name><name><surname>Sjöberg</surname> <given-names>BM</given-names></name></person-group><year iso-8601-date="2006">2006</year><article-title>Ribonucleotide reductase modularity: Atypical duplication of the ATP-cone domain in Pseudomonas aeruginosa</article-title><source>The Journal of Biological Chemistry</source><volume>281</volume><fpage>25287</fpage><lpage>25296</lpage><pub-id pub-id-type="doi">10.1074/jbc.M601794200</pub-id><pub-id pub-id-type="pmid">16829681</pub-id></element-citation></ref><ref id="bib66"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Torrents</surname> <given-names>E</given-names></name></person-group><year iso-8601-date="2014">2014</year><article-title>Ribonucleotide reductases: essential enzymes for bacterial life</article-title><source>Frontiers in Cellular and Infection Microbiology</source><volume>4</volume><elocation-id>52</elocation-id><pub-id pub-id-type="doi">10.3389/fcimb.2014.00052</pub-id><pub-id pub-id-type="pmid">24809024</pub-id></element-citation></ref><ref id="bib67"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Traut</surname> <given-names>TW</given-names></name></person-group><year iso-8601-date="1994">1994</year><article-title>Physiological concentrations of purines and pyrimidines</article-title><source>Molecular and Cellular Biochemistry</source><volume>140</volume><fpage>1</fpage><lpage>22</lpage><pub-id pub-id-type="doi">10.1007/BF00928361</pub-id><pub-id pub-id-type="pmid">7877593</pub-id></element-citation></ref><ref id="bib68"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Watt</surname> <given-names>DL</given-names></name><name><surname>Buckland</surname> <given-names>RJ</given-names></name><name><surname>Lujan</surname> <given-names>SA</given-names></name><name><surname>Kunkel</surname> <given-names>TA</given-names></name><name><surname>Chabes</surname> <given-names>A</given-names></name></person-group><year iso-8601-date="2016">2016</year><article-title>Genome-wide analysis of the specificity and mechanisms of replication infidelity driven by imbalanced dNTP pools</article-title><source>Nucleic Acids Research</source><volume>44</volume><fpage>1669</fpage><lpage>1680</lpage><pub-id pub-id-type="doi">10.1093/nar/gkv1298</pub-id><pub-id pub-id-type="pmid">26609135</pub-id></element-citation></ref><ref id="bib69"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wheeler</surname> <given-names>TJ</given-names></name><name><surname>Clements</surname> <given-names>J</given-names></name><name><surname>Finn</surname> <given-names>RD</given-names></name></person-group><year iso-8601-date="2014">2014</year><article-title>Skylign: a tool for creating informative, interactive logos representing sequence alignments and profile hidden Markov models</article-title><source>BMC Bioinformatics</source><volume>15</volume><elocation-id>7</elocation-id><pub-id pub-id-type="doi">10.1186/1471-2105-15-7</pub-id><pub-id pub-id-type="pmid">24410852</pub-id></element-citation></ref><ref id="bib70"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Winn</surname> <given-names>MD</given-names></name><name><surname>Ballard</surname> <given-names>CC</given-names></name><name><surname>Cowtan</surname> <given-names>KD</given-names></name><name><surname>Dodson</surname> <given-names>EJ</given-names></name><name><surname>Emsley</surname> <given-names>P</given-names></name><name><surname>Evans</surname> <given-names>PR</given-names></name><name><surname>Keegan</surname> <given-names>RM</given-names></name><name><surname>Krissinel</surname> <given-names>EB</given-names></name><name><surname>Leslie</surname> <given-names>AG</given-names></name><name><surname>McCoy</surname> <given-names>A</given-names></name><name><surname>McNicholas</surname> <given-names>SJ</given-names></name><name><surname>Murshudov</surname> <given-names>GN</given-names></name><name><surname>Pannu</surname> <given-names>NS</given-names></name><name><surname>Potterton</surname> <given-names>EA</given-names></name><name><surname>Powell</surname> <given-names>HR</given-names></name><name><surname>Read</surname> <given-names>RJ</given-names></name><name><surname>Vagin</surname> <given-names>A</given-names></name><name><surname>Wilson</surname> <given-names>KS</given-names></name></person-group><year iso-8601-date="2011">2011</year><article-title>Overview of the CCP4 suite and current developments</article-title><source>Acta Crystallographica Section D Biological Crystallography</source><volume>67</volume><fpage>235</fpage><lpage>242</lpage><pub-id pub-id-type="doi">10.1107/S0907444910045749</pub-id><pub-id pub-id-type="pmid">21460441</pub-id></element-citation></ref><ref id="bib71"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wisitpitthaya</surname> <given-names>S</given-names></name><name><surname>Zhao</surname> <given-names>Y</given-names></name><name><surname>Long</surname> <given-names>MJ</given-names></name><name><surname>Li</surname> <given-names>M</given-names></name><name><surname>Fletcher</surname> <given-names>EA</given-names></name><name><surname>Blessing</surname> <given-names>WA</given-names></name><name><surname>Weiss</surname> <given-names>RS</given-names></name><name><surname>Aye</surname> <given-names>Y</given-names></name></person-group><year iso-8601-date="2016">2016</year><article-title>Cladribine and fludarabine nucleotides induce distinct hexamers defining a common mode of reversible RNR inhibition</article-title><source>ACS Chemical Biology</source><volume>11</volume><fpage>2021</fpage><lpage>2032</lpage><pub-id pub-id-type="doi">10.1021/acschembio.6b00303</pub-id><pub-id pub-id-type="pmid">27159113</pub-id></element-citation></ref><ref id="bib72"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Xu</surname> <given-names>H</given-names></name><name><surname>Faber</surname> <given-names>C</given-names></name><name><surname>Uchiki</surname> <given-names>T</given-names></name><name><surname>Fairman</surname> <given-names>JW</given-names></name><name><surname>Racca</surname> <given-names>J</given-names></name><name><surname>Dealwis</surname> <given-names>C</given-names></name></person-group><year iso-8601-date="2006">2006</year><article-title>Structures of eukaryotic ribonucleotide reductase I provide insights into dNTP regulation</article-title><source>PNAS</source><volume>103</volume><fpage>4022</fpage><lpage>4027</lpage><pub-id pub-id-type="doi">10.1073/pnas.0600443103</pub-id><pub-id pub-id-type="pmid">16537479</pub-id></element-citation></ref><ref id="bib73"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zheng</surname> <given-names>M</given-names></name><name><surname>Khangulov</surname> <given-names>SV</given-names></name><name><surname>Dismukes</surname> <given-names>GC</given-names></name><name><surname>Barynin</surname> <given-names>VV</given-names></name></person-group><year iso-8601-date="1994">1994</year><article-title>Electronic structure of dimanganese(II,III) and dimanganese(III,IV) complexes and dimanganese catalase enzyme: a general EPR spectral simulation approach</article-title><source>Inorganic Chemistry</source><volume>33</volume><fpage>382</fpage><lpage>387</lpage><pub-id pub-id-type="doi">10.1021/ic00080a030</pub-id></element-citation></ref><ref id="bib74"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zimanyi</surname> <given-names>CM</given-names></name><name><surname>Chen</surname> <given-names>PY</given-names></name><name><surname>Kang</surname> <given-names>G</given-names></name><name><surname>Funk</surname> <given-names>MA</given-names></name><name><surname>Drennan</surname> <given-names>CL</given-names></name></person-group><year iso-8601-date="2016">2016</year><article-title>Molecular basis for allosteric specificity regulation in class Ia ribonucleotide reductase from Escherichia coli</article-title><source>eLife</source><volume>5</volume><elocation-id>e07141</elocation-id><pub-id pub-id-type="doi">10.7554/eLife.07141</pub-id><pub-id pub-id-type="pmid">26754917</pub-id></element-citation></ref></ref-list></back><sub-article article-type="decision-letter" id="SA1"><front-stub><article-id pub-id-type="doi">10.7554/eLife.31529.022</article-id><title-group><article-title>Decision letter</article-title></title-group><contrib-group><contrib contrib-type="editor"><name><surname>Berger</surname><given-names>James M</given-names></name><role>Reviewing Editor</role><aff><institution>Johns Hopkins University School of Medicine</institution><country>United States</country></aff></contrib></contrib-group></front-stub><body><boxed-text><p>In the interests of transparency, eLife includes the editorial decision letter and accompanying author responses. A lightly edited version of the letter sent to the authors after peer review is shown, indicating the most substantive concerns; minor comments are not usually included.</p></boxed-text><p>Thank you for submitting your article &quot;Unique ATP-cone-driven allosteric regulation of ribonucleotide reductase via the radical-generating subunit&quot; for consideration by <italic>eLife</italic>. Your article has been reviewed by two peer reviewers, and the evaluation has been overseen by a Reviewing Editor and Michael Marletta as the Senior Editor. The following individual involved in review of your submission has agreed to reveal his identity: Christopher K Mathews (Reviewer #3).</p><p>The reviewers have discussed the reviews with one another and the Reviewing Editor has drafted this decision to help you prepare a revised submission.</p><p>Summary:</p><p>In the present work, Grinberg et al. describe the structure and function of a ribonucleotide reductase (RNR) from the bacterium, L. blandensis. RNR is an essential enzyme that plays a key role in DNA synthesis and repair, and is a textbook exemplar for allosteric regulation in enzymes. The current paper is well-written and relies on multiple techniques and contributions from several groups in the RNR field. The most significant finding is that a well-studied region of RNRs called the ATP cone, which comprises the regulatory site for controlling RNR activity and is usually located on the large subunit of the heteromeric complex, is unexpectedly found to reside in the small subunit, which generates the free radical required for enzyme catalysis. This observation represents a substantial paradigm shift in the RNR world.</p><p>Essential revisions:</p><p>1) In the present work, dADP is shown for the first time to act as an allosteric inhibitor. dADP appears to have half the affinity for the activity site compared to the canonical allosteric inhibitor, dATP. Does this finding imply that dADP has a physiological role in regulation? What is the effect of dADP on oligomerization compared to dATP? The k<sub>on</sub> for dADP should be compared between L. blandensis RNR and the triphosphate-forming kinases that convert dADP to dATP to see whether such a role is feasible. In light of this unusual finding concerning dADP regulation, it is important to carry out a comparison of the binding sites between the L. blandensis structure and the ligand-bound ATP cones from <italic>E. coli</italic> and/or human RNR. Such an analysis may reveal why dADP is not an allosteric inhibitor in <italic>E. coli</italic> or human RNR when it is in L. blandensis. A comparative ITC experiment would be useful to shed light on dADP binding between species, while an anomalous scattering experiment would help solidify the identity of the metal ions observed in the L. blandensis RNR metal cluster and activity site.</p><p>2) Two ATP molecules are found to be bound in the activity site of L. blandensis RNR. What is the role of the second one? Based on early work with the eukaryotic RNRs, it was shown that oligomerization is induced by ATP or dATP binding – what is the driving force for oligomerization here? Please address whether the oligomerization phenomena be validated in this system using site-directed mutants.</p><p>3) Some additional explanation is required with the GEMMA analysis. In <xref ref-type="fig" rid="fig4">Figure 4B</xref>, the NrdBΔ99 mutant appears to form monomers, dimers, and trimers without any effector present. Please explain how this is possible. Is it due to error in the dimer and trimer molecular weights, or is there a problem with the approach? <xref ref-type="fig" rid="fig4">Figure 4C</xref> shows NrdA is able to form monomers and dimers in the absence of an effector. Please explain why this is – is dimerization due to mass action? In the second trace, where 50 μM of dATP is added, monomers and dimers both appear; however, the monomer is slightly more populated than the dimer. Please explain. Is there any reason, as with other RNR's (such as eukaryotic or <italic>E. coli</italic>), why the dimer population is not dominant?</p><p>4) Several assumptions have been made based on the structure in interpreting the ITC data. For example, the number of dATP binding sites is assumed to be two because that is what is seen crystallographically. This stoichiometry should be dealt in an unbiased way by fitting the data to different numbers of sites and using the fit with least error to select the correct model.</p><p>5) Comparison of the ΔH values between the different ligands gives a rather surprising value for dADP, which is at least 24 kJ/mol higher than the dATP. This difference implies that several additional hydrogen bonds, ion-pairs, and/or van der Waals interactions are made by dADP compared to dATP. Yet the structure indicates that dATP makes only a single an additional hydrogen bond compared to the dADP. This discordance between the ITC and structural data should be explained.</p><p>6) The significance of the work should be better clarified for a general (non-RNR) audience. Given the wealth of important enzyme systems in biology, why are the current findings important for advancing our understanding of broad issues, such as allosteric regulations, the appropriate control of nucleotide levels to avoid disease states, etc. Along these lines, the discussion of the potential applications of the findings is brief and unsatisfying. It is claimed that the new observations offer a possible route to regulate engineered enzymes by dATP inhibition. Please elaborate on this concept and how it might work.</p><p>Reviewer #2:</p><p>Grinberg et al. describe the structure and function of L. blandensis this is a well-written paper that have contributions of many groups from Sweden that work on Rnr. The major finding in this work is that the ATP cone where lies the activity site, usually located on the large subunit is now found in the small subunit housing the essential free radical. This was totally unexpected and is an important finding that furthers our understanding of Rnr. However, there are some important questions that are prompted by this work, which requires some answers. For example, dADP for the first time shown to act as an allosteric inhibitor. The dADP has half the affinity for the activity site compared to the allosteric inhibitor dATP. Therefore, does this dADP have a physiological role in regulation? For example, what is its efficiency on oligomerization compared to dATP? An experiment with dNTP pool analysis will be required to show if the ADP has a physiological role to play. One would have to compare the k<sub>on</sub> for the dADP between Rnr and the triphosphate converting kinases that convert the dADP to dATP to see if this is feasible. In the light of this unusual finding, it is important to do a comparison of the binding sites between the L. blandensis structure and the <italic>E. coli</italic>. or human ligand bound ATP cones. This may reveal why ADP is not an allosteric inhibitor in <italic>E. coli</italic>. or human while it is in L. blandensis. Perhaps a comparative ITC experiment might shed light between species. In anomalous scattering experiment would shed light on the identity of the metal ions both on the metal cluster and activity site.</p><p>Two ATP molecules are bound in the activity site. What is the role of the second one? Based on the early work with the eukaryotic RNR's it was shown that the oligomerization is induced by ATP or dATP binding what is the force driving the oligomerization here? Can you validate the oligomerization phenomena in the system using site – directed mutants?</p><p>Reviewer #3:</p><p>This is a major paper, using multiple benchmark techniques, that explores an unexpected finding-that a newly characterized form of ribonucleotide reductase contains its &quot;activity site,&quot; AKA ATP-cone, on the small (radical-containing) subunit. A substantial paradigm shift in the RNR world. I have just three suggestions for improving this outstanding paper.</p><p>1) Change &quot;Unique&quot; to &quot;Novel&quot; in the title, inasmuch as several different bacteria have been found to share this unexpected property, not just the species chosen for study in this paper.</p><p>2) Define the criteria, either amino acid sequence or 3D structure, by which an amino acid sequence of about 100 residues is identified as an &quot;ATP-cone.&quot;</p><p>3) Either delete the last sentence in the Abstract or (preferably) modify the discussion appropriately, because the discussion of potential applications of the findings in this paper is brief and unsatisfying.</p></body></sub-article><sub-article article-type="reply" id="SA2"><front-stub><article-id pub-id-type="doi">10.7554/eLife.31529.023</article-id><title-group><article-title>Author response</article-title></title-group></front-stub><body><disp-quote content-type="editor-comment"><p>Essential revisions:</p><p>1) In the present work, dADP is shown for the first time to act as an allosteric inhibitor. dADP appears to have half the affinity for the activity site compared to the canonical allosteric inhibitor, dATP. Does this finding imply that dADP has a physiological role in regulation?</p></disp-quote><p>Actually, dADP has an affinity which is only a fifteenth of the dATP affinity (<xref ref-type="fig" rid="fig8">Figure 8F</xref>) and because of that we believe that dATP is the main physiological allosteric effector. However, the relative affinity for dADP compared to dATP is still higher than in most other RNRs and we cannot exclude the possibility that local concentrations around the enzyme might be high enough to actually have a physiological effect. Nevertheless, we have modified the text to make it clear that we believe that dATP is the main physiological effector of the two.</p><disp-quote content-type="editor-comment"><p>What is the effect of dADP on oligomerization compared to dATP? The k<sub>on</sub> for dADP should be compared between L. blandensis RNR and the triphosphate-forming kinases that convert dADP to dATP to see whether such a role is feasible.</p></disp-quote><p>The main message of our current study is the transfer of an ATP-cone domain from the catalytic subunit of an RNR to its corresponding radical-containing subunit, and that the ATP-cone confers similar effects of dATP and ATP to the oligomeric status of the NrdB subunit. We would therefore prefer not to focus the current study on the binding of dADP to the ATP-cone, as we have shown that the binding of dADP is only a fifteenth compared to binding of dATP. Both dADP and dATP induce the formation of NrdB tetramers but the effect of dADP is weaker. We have replaced the dADP experiment in <xref ref-type="fig" rid="fig4">Figure 4</xref><xref ref-type="fig" rid="fig3">A</xref> with a more representative one. The main conclusion, that both nucleotides induce the formation of NrdB tetramers, is the same. The isotherms for calculating k<sub>on</sub> values for dADP association with <italic>L. blandensis</italic> NrdB have a subtle shoulder relating to the fact that the two sites are probably not totally equivalent and the rough estimates are 3x10<sup>3</sup> s<sup>-1</sup>M<sup>-1</sup>s<sup>-1</sup>, compared to human nucleoside diphosphate kinase with k<sub>on</sub> values for dADP in the order of 4.5x10<sup>6</sup> s<sup>-1</sup>M<sup>-1</sup>s<sup>-1</sup> (Schaertl &amp; al, J Biol Chem 1998, 273: 5662). Kinetic parameters derived from the ITC isotherm were obtained using the AFFINImeter software assuming a 1:1 interaction model, according to the method described in J. Am. Chem. Soc., 2012, 134(1), 559-565 (see eq. 4 in Suppl. Information) and Dumas et al. (2016), Methods in Enzymology, Vol. 567, Chap. 7, A.Feig Ed.</p><disp-quote content-type="editor-comment"><p>In light of this unusual finding concerning dADP regulation, it is important to carry out a comparison of the binding sites between the L. blandensis structure and the ligand-bound ATP cones from E. coli and/or human RNR. Such an analysis may reveal why dADP is not an allosteric inhibitor in E. coli or human RNR when it is in L. blandensis.</p></disp-quote><p>The <italic>L. blandensis</italic> ATP cone belongs to the recently-identified family of ATP cones that bind two molecules of dATP rather than only one, as in the human and <italic>E. coli</italic> enzymes. A detailed comparison of the two types of ATP cone was already made for its occurrence in the NrdA protein from <italic>Pseudomonas aeruginosa</italic> in Johansson et al., 2016. The ability to bind a second dATP molecule is due to the presence of a unique sequence motif in the C-terminal helix of the ATP cone domain that is not present in human or <italic>E. coli</italic> RNR. The interactions are essentially identical in the <italic>L. blandensis</italic> ATP cone, thus such a comparison would be superfluous in this paper. Nevertheless, one can speculate that, since the two dATP molecules bind with their triphosphate tails coordinating a Mg<sup>2+</sup> ion, the loss of the γ phosphate group in dADP would have a relatively minor effect on affinity, as this group makes only one polar interaction with the protein in one of the two dATP molecules. On the other hand, this appears to be the case for the <italic>E. coli</italic> and human ATP cones as well. We hypothesize that the effect of loss of this single interaction is less when two dATP molecules are bound than when there is only one.</p><disp-quote content-type="editor-comment"><p>A comparative ITC experiment would be useful to shed light on dADP binding between species, while an anomalous scattering experiment would help solidify the identity of the metal ions observed in the L. blandensis RNR metal cluster and activity site.</p></disp-quote><p>Anomalous diffraction experiments have been done at three wavelengths (1.72 Å, 1.87 Å and 1.92 Å) that should help discriminate between Fe, Mn and Ca. The results suggest that the metal centre is filled with Ca<sup>2+</sup> ions from the crystallization medium. This data was added to the main text. ITC studies on dADP binding to other species are beyond the scope of our current study, as we have determined dADP binding to be more than an order of magnitude worse than dATP binding and in vivo concentrations of dNDP in general are known to be low compared to dNTP concentrations.</p><disp-quote content-type="editor-comment"><p>2) Two ATP molecules are found to be bound in the activity site of L. blandensis RNR. What is the role of the second one? Based on early work with the eukaryotic RNRs, it was shown that oligomerization is induced by ATP or dATP binding – what is the driving force for oligomerization here? Please address whether the oligomerization phenomena be validated in this system using site-directed mutants.</p></disp-quote><p>For the new type of ATP cone observed in this enzyme, this question was already addressed quite extensively from a structural point of view in Johansson et al., 2016, where the structure of such a domain was seen for the first time in NrdA from <italic>P. aeruginosa.</italic> The domain was characterized biochemically in a previous paper from the Hofer lab (Jonna et al., 2015). Site-directed mutants were made in the <italic>P. aeruginosa</italic> NrdA interaction surface that abolished tetramerization. Since the interface residues are conserved in <italic>L. blandensis</italic> NrdB and the interactions between ATP cones are almost identical, we do not think it necessary to re-make these mutations.</p><p>Regarding the role of the second dATP molecule, this was also covered in Johansson et al., 2016. Inhibition is driven by dATP binding to both kinds of ATP cones (binding one or two dATPs). This induces conformational changes in the domain that leads them to associate, either with each other (as in yeast, human, <italic>P. aeruginosa</italic> and <italic>L. blandensis</italic>) or with NrdB (as in <italic>E. coli)</italic>. The ATP-induced oligomerization is unique to eukaryotic RNRs and has not been characterized structurally. The <italic>L. blandensis</italic> type of ATP cone domain uses a different surface to oligomerize (building tetramers) than what eukaryotes or <italic>E. coli</italic> do, and interestingly this is the surface closest to the second dATP molecule.</p><disp-quote content-type="editor-comment"><p>3) Some additional explanation is required with the GEMMA analysis. In <xref ref-type="fig" rid="fig4">Figure 4B</xref>, the NrdBΔ99 mutant appears to form monomers, dimers, and trimers without any effector present. Please explain how this is possible. Is it due to error in the dimer and trimer molecular weights, or is there a problem with the approach? <xref ref-type="fig" rid="fig4">Figure 4C</xref> shows NrdA is able to form monomers and dimers in the absence of an effector. Please explain why this is – is dimerization due to mass action? In the second trace, where 50 μM of dATP is added, monomers and dimers both appear; however, the monomer is slightly more populated than the dimer. Please explain. Is there any reason, as with other RNR's (such as eukaryotic or E. coli), why the dimer population is not dominant?</p></disp-quote><p>The NrdBΔ99 mutant is mainly a monomer but with a slight tendency to aggregate non-specifically in the ammonium acetate buffer. A typical pattern of aggregation is a ladder of dimers, trimers, tetramers etc, which you also see in the figure. Another possibility could also be false interactions, but by comparing the analysis at many different flow-rates (different pressures), we found that this is less likely. Generally, the role of tiny peaks (now shown in brackets) should not be overemphasized in GEMMA (the trimers, tetramers etc can be regarded minor in this sense whereas the monomers and dimers are much higher). It is not surprising that the NrdA protein is in a monomer-dimer equilibrium already without effector, since there is a great variation between species. For example, the mammalian protein is a monomer and the <italic>E. coli</italic> protein is in a monomer-dimer equilibrium. The relative amounts of monomers and dimers are dependent on the protein concentration. As the reviewer has pointed out, it is a bit surprising that nucleotide effectors do not have as strong effect on dimerization as in most other species studied. All these points are now explained in the text.</p><disp-quote content-type="editor-comment"><p>4) Several assumptions have been made based on the structure in interpreting the ITC data. For example, the number of dATP binding sites is assumed to be two because that is what is seen crystallographically. This stoichiometry should be dealt in an unbiased way by fitting the data to different numbers of sites and using the fit with least error to select the correct model.</p></disp-quote><p>N values in ITC fits are strongly affected by the content of <italic>active</italic> protein material as opposed to total protein concentration. In all the nucleotide titrations the fitted apparent N value was significantly above 1 when total protein concentration was used. However, for the N value to be meaningful in terms of stoichiometry it has to be an integer. Using N=1 for dATP binding the active protein concentration becomes more than 100% of the total concentration, whereas using N=2 gives an active protein concentration of 60%, in our experience a typical fraction of active RNR (the error of the fit will not change whether the N value or the active protein concentration is fixed). The proportion of inactive protein can be explained by e.g. aggregation as observed by SEC-MALS and DLS. Moreover, our X-ray crystallography shows a stoichiometry of 2 bound dATP molecules. For meaningful results, we therefore used the active protein concentration for calculation of ATP and dADP binding stoichiometries.</p><disp-quote content-type="editor-comment"><p>5) Comparison of the ΔH values between the different ligands gives a rather surprising value for dADP, which is at least 24 kJ/mol higher than the dATP. This difference implies that several additional hydrogen bonds, ion-pairs, and/or van der Waals interactions are made by dADP compared to dATP. Yet the structure indicates that dATP makes only a single an additional hydrogen bond compared to the dADP. This discordance between the ITC and structural data should be explained.</p></disp-quote><p>The overall enthalpy of the reaction, measured by calorimetry, is affected not only by direct protein interaction with the ligand, but also by water molecules in the binding pocket (Klebe, Nature Rev Drug Discovery 2015, 14: 95). Since calorimetry measures the overall effect of all changes in the binding pocket, it is hard to correlate and compare enthalpies without structural data for the dADP bound complex.</p><disp-quote content-type="editor-comment"><p>6) The significance of the work should be better clarified for a general (non-RNR) audience. Given the wealth of important enzyme systems in biology, why are the current findings important for advancing our understanding of broad issues, such as allosteric regulations, the appropriate control of nucleotide levels to avoid disease states, etc. Along these lines, the discussion of the potential applications of the findings is brief and unsatisfying. It is claimed that the new observations offer a possible route to regulate engineered enzymes by dATP inhibition. Please elaborate on this concept and how it might work.</p></disp-quote><p>We have added a sentence to the Abstract, a paragraph to the Discussion, plus a few references in the Introduction, describing the degree of novelty of our finding. That allosteric regulation controlled by modular domains is evolutionarily dynamic has been shown before (by us and others), but we are not aware of other enzyme complexes in which a domain has transferred to a non-homologous component. We would like to argue that this, in addition to the general importance of ribonucleotide reduction and its control in all organisms, makes our finding interesting to a broad audience of biologists interested in evolution of proteins, nucleotide metabolism and enzyme structure and function. In addition, we have added a few sentences at the end of the fourth paragraph in the Introduction describing briefly that RNRs are potential targets both for antibacterial and antitumor therapies. We have also added a sentence to the Introduction describing in some more detail how we foresee that ATP-cones could be used to confer regulation of engineered enzymes by control of nucleotide concentrations, at least for enzymes that are sensitive to oligomerization states. Since this is not within our direct area of expertise, we fear that further detail would become too speculative.</p></body></sub-article></article>